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A B S T R A C T
Background
Point-of-care (POC) tests for diagnosing schistosomiasis include tests based on circulating antigen detection and urine reagent strip
tests. If they had sufficient diagnostic accuracy they could replace conventional microscopy as they provide a quicker answer and are
easier to use.
Objectives
To summarise the diagnostic accuracy of: a) urine reagent strip tests in detecting active Schistosoma haematobium infection, with
microscopy as the reference standard; and b) circulating antigen tests for detecting active Schistosoma infection in geographical regions
endemic for Schistosoma mansoni or S. haematobium or both, with microscopy as the reference standard.
Search methods
We searched the electronic databases MEDLINE, EMBASE, BIOSIS, MEDION, and Health Technology Assessment (HTA) without
language restriction up to 30 June 2014.
Selection criteria
We included studies that used microscopy as the reference standard: for S. haematobium, microscopy of urine prepared by filtration,
centrifugation, or sedimentation methods; and for S. mansoni, microscopy of stool by Kato-Katz thick smear. We included studies on
participants residing in endemic areas only.
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Data collection and analysis
Two review authors independently extracted data, assessed quality of the data using QUADAS-2, and performed meta-analysis where
appropriate. Using the variability of test thresholds, we used the hierarchical summary receiver operating characteristic (HSROC)
model for all eligible tests (except the circulating cathodic antigen (CCA) POC for S. mansoni, where the bivariate random-effects
model was more appropriate). We investigated heterogeneity, and carried out indirect comparisons where data were sufficient. Results
for sensitivity and specificity are presented as percentages with 95% confidence intervals (CI).
Main results
We included 90 studies; 88 from field settings in Africa. The median S. haematobium infection prevalence was 41% (range 1% to 89%)
and 36% for S. mansoni (range 8% to 95%). Study design and conduct were poorly reported against current standards.
Tests for S. haematobium
Urine reagent test strips versus microscopy
Compared to microscopy, the detection of microhaematuria on test strips had the highest sensitivity and specificity (sensitivity 75%,
95% CI 71% to 79%; specificity 87%, 95% CI 84% to 90%; 74 studies, 102,447 participants). For proteinuria, sensitivity was 61%
and specificity was 82% (82,113 participants); and for leukocyturia, sensitivity was 58% and specificity 61% (1532 participants).
However, the difference in overall test accuracy between the urine reagent strips for microhaematuria and proteinuria was not found
to be different when we compared separate populations (P = 0.25), or when direct comparisons within the same individuals were
performed (paired studies; P = 0.21).
When tests were evaluated against the higher quality reference standard (whenmultiple samples were analysed), sensitivity wasmarginally
lower for microhaematuria (71% vs 75%) and for proteinuria (49% vs 61%). The specificity of these tests was comparable.
Antigen assay
Compared to microscopy, the CCA test showed considerable heterogeneity; meta-analytic sensitivity estimate was 39%, 95% CI 6%
to 73%; specificity 78%, 95% CI 55% to 100% (four studies, 901 participants).
Tests for S. mansoni
Compared to microscopy, the CCA test meta-analytic estimates for detecting S. mansoni at a single threshold of trace positive were:
sensitivity 89% (95% CI 86% to 92%); and specificity 55% (95% CI 46% to 65%; 15 studies, 6091 participants) Against a higher
quality reference standard, the sensitivity results were comparable (89% vs 88%) but specificity was higher (66% vs 55%). For the CAA
test, sensitivity ranged from 47% to 94%, and specificity from 8% to 100% (four studies, 1583 participants).
Authors’ conclusions
Among the evaluated tests for S. haematobium infection, microhaematuria correctly detected the largest proportions of infections and
non-infections identified by microscopy.
The CCA POC test for S. mansoni detects a very large proportion of infections identified by microscopy, but it misclassifies a large
proportion of microscopy negatives as positives in endemic areas with a moderate to high prevalence of infection, possibly because the
test is potentially more sensitive than microscopy.
P L A I N L A N G U A G E S U M M A R Y
How well do point-of-care tests detect Schistosoma infections in people living inendemic areas?
Schistosomiasis, also known as bilharzia, is a parasitic disease common in the tropical and subtropics. Point-of-care tests and urine
reagent strip tests are quicker and easier to use than microscopy. We estimate how well these point-of-care tests are able to detect
schistosomiasis infections compared with microscopy.
We searched for studies published in any language up to 30 June 2014, and we considered the study’s risk of providing biased results.
What do the results say?
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We included 90 studies involving almost 200,000 people, with 88 of these studies carried out in Africa in field settings. Study design
and conduct were poorly reported against current expectations. Based on our statistical model, we found:
• Among the urine strips for detecting urinary schistosomiasis, the strips for detecting blood were better than those detecting protein
or white cells (sensitivity and specificity for blood 75% and 87%; for protein 61% and 82%; and for white cells 58% and 61%,
respectively).
• For urinary schistosomiasis, the parasite antigen test performance was worse (sensitivity, 39% and specificity, 78%) than urine strips
for detecting blood.
• For intestinal schistosomiasis, the parasite antigen urine test, detected many infections identified by microscopy but wrongly labelled
many uninfected people as sick (sensitivity, 89% and specificity, 55%).
What are the consequences of using these tests?
If we take 1000 people, of which 410 have urinary schistosomiasis on microscopy testing, then using the strip detecting blood in the
urine would misclassify 77 uninfected people as infected, and thus may receive unnecessary treatment; and it would wrongly classify
102 infected people as uninfected, who thus may not receive treatment.
If we take 1000 people, of which 360 have intestinal schistosomiasis on microscopy testing, then the antigen test would misclassify
288 uninfected people as infected. These people may be given unnecessary treatment. This test also would wrongly classify 40 infected
people as uninfected who thus may not receive treatment.
Conclusion of review
For urinary schistosomiasis, the urine strip for detecting blood leads to some infected people being missed and some non-infected
people being diagnosed with the condition, but is better than the protein or white cell tests. The parasite antigen test is not accurate.
For intestinal schistosomiasis, the parasite antigen urine test classifies many microscopy negative people as being infected. This finding
may be explained by the low sensitivity of microscopy.
B A C K G R O U N D
Target condition being diagnosed
Schistosomiasis, also known as bilharzia, is the second major para-
sitic disease affecting tropical and subtropical regions aftermalaria.
It is caused by trematode worms of the genus Schistosoma (Gryseels
2012). The latest estimates show that schistosomiasis is endemic
in 76 countries, with 779 million people at risk of infection and
approximately 207 million people currently infected. Sub-Saha-
ran Africa accounts for more than 90% of current cases of schisto-
somiasis (Engels 2002; WHO 2010; Gryseels 2012). The global
burden of disease in 2004 was estimated at 13 to 15 million dis-
ability-adjusted life-years (DALYs) lost as the result of schistoso-
miasis (King 2010a). These estimates could be an underestimate
resulting from the low sensitivity of routinely used diagnostic tests
(King 2010a; King 2010b).
Five main schistosome species are known to infect man (Schis-
tosoma mansoni, Schistosoma haematobium,Schistosoma japonicum,
Schistosoma intercalatum, and Schistosoma mekongi), of which S.
mansoni, S. haematobium, and S. japonicum have the greatest im-
pact on morbidity (Gryseels 2006). The focus of this review will
be on diagnosing infection caused by S. mansoni and S. haema-
tobium, as they are more widespread globally and account for
most infections and associatedmorbidityworldwide. These species
cause intestinal schistosomiasis and urogenital schistosomiasis, re-
spectively. As outlined in Appendix 1, urogenital schistosomia-
sis presents with blood in urine (haematuria), proteins in urine
(proteinuria), or white blood cells in urine (leukocyturia). In its
chronic form, it presents with major bladder, kidney, and genital
pathologies including chronic renal failure. Intestinal schistoso-
miasis presents with abdominal pain and in its chronic and severe
forms can present with enlarged liver (hepatomegaly), abdomen
distended with fluid (ascites), and liver failure.
Currently, no vaccine is available to protect against schistosomal
infection (Rollinson 2009; Bethony 2011). If left untreated, schis-
tosomal infection may result in chronic disease. The current drug
of choice is praziquantel, which is cheap (costing less than USD
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0.15 per treatment) and safe and causes few side effects. Praziquan-
tel however is ineffective against the eggs and larval forms of schis-
tosome worms (Gryseels 2012; Rollinson 2013). Mass praziquan-
tel treatment of populations at risk of infection is now routine in
many endemic areas (WHO 2010; Rollinson 2013). Reinfections
rapidly occur as the result of recurrent direct contact with water
bodies infected with schistosomal parasites (WHO/TDR 2006;
Rollinson 2009; Rollinson 2013). No strong evidence of clinically
relevant drug resistance is available (Geerts 2001; Doenhoff 2002;
Fenwick 2003; Doenhoff 2009; Greenberg 2013). However re-
ports have described heterogeneities in egg reduction rates and
in systematic non-clearers of infection after treatment with praz-
iquantel (Black 2009; Melman 2009; Ahmed 2012). In the long
run, mass treatment has limitations related to cost-effectiveness
(French 2010), poor sustainability (Utzinger 2009), poor drug
compliance by individuals (Guo 2005; Croce 2010), and increased
drug selection pressure (Greenberg 2013).
Accurate and affordable diagnostic tools are essential for provid-
ing targeted treatment and for maximizing the success of control
of schistosomiasis in endemic areas; they are required for moni-
toring drug efficacy as well. Diagnosis of schistosomiasis can be
performed directly or indirectly. Direct methods include detection
of schistosome eggs in urine or stool by microscopy, detection of
schistosome antigens in serum or urine samples, and detection of
Schistosoma-specific DNA in urine, stool, or blood. Indirect meth-
ods include questionnaires, biochemical tests (urine reagent strips
formicrohaematuria/proteinuria/leukocyturia), antibody tests, ul-
trasonography, computed tomography (CT) scan, magnetic reso-
nance imaging (MRI) scan, endoscopy, and cystoscopy (Feldmeier
1993;Rabello 1997;Doenhoff 2004; Bichler 2006;Gryseels 2012;
Cavalcanti 2013).
Currently no gold standard is recommended for the detection of
schistosomiasis. Microscopy is the most widely used test for diag-
nosing schistosomiasis and, although imperfect, it is commonly
used as the reference standard in practice. Its sensitivity has been
shown to vary with intensity of infection, prevalence of infec-
tion, sample preparation techniques, stool consistency, and circa-
dian and day-to-day variation of egg counts in stool and/or urine
(Doehring 1983;Doehring 1985a; Rabello 1992; Feldmeier 1993;
Rabello 1997; van Lieshout 2000; Knopp 2008). This becomes
particularly pertinent as control programmes progress and sensi-
tivity of microscopy decreases as the result of reduced infection in-
tensity. Repeated measurements over multiple days from multiple
samples and/or multiple smears/slides taken from each sample has
been shown to increase sensitivity (Knopp 2008; da Frota 2011;
Siqueira 2011; Deelder 2012); however this task increases the time
taken to perform the survey and therefore becomes logistically ex-
pensive (van Lieshout 2000; Legesse 2007).
Index test(s)
Urine reagent strips and circulating antigen tests are used as alter-
natives to microscopy for diagnosis of schistosomiasis. Compared
with microscopy, urine reagent strips used to detect microhaema-
turia or proteinuria as a proxy for S. haematobium infection are
cheap, quick, and easy to use (Mott 1985; Brooker 2009); have
no technical requirements; and are less influenced by the circadian
production of schistosome eggs (Murare 1987; Lengeler 1991b).
Furthermore, some studies have shown that the sensitivity of these
strips is higher than that of urine filtration (French 2007;Robinson
2009), and that a single test with microhaematuria strips is more
sensitive than a single test with urine filtration (Taylor 1990)-fea-
tures that make these strips suitable for screening of urogenital
schistosomiasis in the field. However, results should be interpreted
against the background of risk for schistosomiasis, as well as any
other signs and symptoms that could be indicative of other dis-
eases. Microhaematuria and proteinuria are non-specific signs that
could also result from other ailments such as urogenital infection,
malignancy, immune system disorders, metabolic disorders, and
trauma.
Circulating antigen tests (circulating anodic antigen (CAA) and
circulating cathodic antigen (CCA)) have also been evaluated as
replacements for microscopy in the diagnosis of infection due to S.
haematobium or S. mansoni. These tests can differentiate between
active and past infections, as the circulating antigens are probably
present only when there is active infection (Doenhoff 2004). As
circulating antigens are released from living worms, antigen levels
may correlate directly with parasite load, whilst microscopy does
not. This may make the CCA POC test useful in monitoring the
dynamics of worm burdens and clearance of worms after treat-
ment (Cavalcanti 2013; Rollinson 2013). However, the sensitiv-
ity of these tests has been shown to vary with prevalence of dis-
ease and intensity of infection (De Jonge 1988; De Jonge 1989;
van Lieshout 1992; De Clerq 1997; Stothard 2006; Ayele 2008;
Obeng 2008; Midzi 2009; Colley 2013).
This review evaluates the urine CCA POC test, urine CCA and
CAA enzyme-linked immunosorbent assay (ELISA), and serum
CCA and CAA ELISA. The urine CCA POC test is a lateral flow
assay that uses a nitrocellulose strip with a monoclonal antibody-
coated test line to detect the presence of Schistosoma-specific CCA
antigen in urine. When urine from an infected individual flows
through the strip, the antigen will bind to the test line, which
becomes visible with the binding of added labelled monoclonal
antibodies (van Dam 2004). Of note, the urine CCA POC test
was developed based on the performance of the ELISA format
(Brooker 2009). The urine CCA ELISA was found to have the
best diagnostic performance, followed by the serum CAA assay
for S. mansoni (Polman 1995; van Lieshout 1995; van Lieshout
2000). Therefore, although they are not rapid tests, the accuracy
measures of ELISA tests will be systematically assessed, as the sum-
mary measures obtained may guide the ongoing development of
improved POC tests.
So far, a range of accuracy measures have been reported for urine
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reagent tests and for circulating antigen tests. Diagnostic and treat-
ment strategies in endemic areas vary with results of these tests
(Appendix 2) and depend on financial and human resource capac-
ity.
Clinical pathway
Patients suspected of having active S. haematobium or S. mansoni
infection in endemic settings.
Prior test(s)
As outlined in Appendix 2, current practice in endemic settings is
to use urine reagent strips as a replacement for microscopy or as
a triage test (before microscopy), or circulating antigen tests as a
replacement formicroscopy. In line with practice in disease control
programmes, we focus on the role of these tests as alternatives to
microscopy. We will not consider prior testing with other tests, as
this is rarely done in public health programmes.
Role of index test(s)
We are interested in the following purposes for testing.
• Reagent strips to detect microhaematuria, proteinuria, or
leukocyturia as a replacement test for microscopy for S.
haematobium infection.
• CCA point-of-care test as a replacement test for microscopy
for S. haematobium or S. mansoni infection.
Alternative test(s)
Apart from the two test types mentioned above, a range of other
tests can be used to screen for schistosomiasis. However, all are
used in different situations and in different circumstances than the
tests mentioned above.
Questionnaires have been used for the initial rapid screening for
urinary schistosomiasis in high-risk communities in endemic areas
(Lengeler 1991a; Feldmeier 1993; Chitsulo 1995). These ques-
tionnaires rely on self-reporting of blood in urine. Studies have
shown that questionnaires demonstrate moderate to high sensi-
tivities and specificities when used to screen individuals for uro-
genital schistosomiasis in high-prevalence areas but low sensitivity
and specificity in low-prevalence areas (Lengeler 1991a; Lengeler
1991b; Brooker 2009). Questionnaires for intestinal schistosomi-
asis have been shown to be less sensitive and specific than those
for urogenital schistosomiasis (WHO/TDR 2006; Brooker 2009).
Symptoms of intestinal schistosomiasis are associated with many
other diseases, which often overlap in range. As co-infection is the
norm rather than a rare occurrence, the questionnaires are less spe-
cific. The accuracy of questionnaires has been shown to be influ-
enced by age and gender.When questionnaires are used repeatedly
in the same area, respondents are prone to give biased answers, as
they know the consequences of the answers they give. Thus, recall
bias may interfere with the accuracy of the test. Consequently,
relying on questionnaires may become ineffective, making this
screening method unsuitable even for follow-up of patients after
treatment (Ansell 1997; Guyatt 1999; Lengeler 2002). As ques-
tionnaires are recommendedmainly for initial rapid screening and
not for routine screening for schistosomiasis, they will not be eval-
uated in this review.
Serology tests are alternative tests for the diagnosis of schistoso-
miasis. These tests detect antibodies against worm antigens, egg
antigens (soluble egg antigens (SEAs)), or eosinophil cationic pro-
teins (ECPs) (Reimert 1991; Feldmeier 1993; ITM 2007). Avail-
able methods include ELISA, indirect immunofluorescence assay
(IFA), and indirect haemagglutination assay (IHA). Antibody tests
demonstrate high sensitivity even in areas with light infection and
therefore can be used in areas with low endemicity. However these
tests fall short in distinguishing current active infection from past
infection, have low specificity in endemic areas because of cross-re-
activity with antigens of other helminths, and often show antibody
levels that remain elevated after treatment; therefore they yield
many false-positive results (Doenhoff 2004;Cavalcanti 2013). An-
tibody tests may have a role in checking for maintained exposure
to schistosomiasis in areas that are moving towards elimination
(Rollinson 2013).
The ECP test is an indirect marker of S. haematobium infec-
tion and related morbidity (Reimert 2000; Vennervald 2004).
Other test examples include rectal biopsy (ITM 2007), cystoscopy
and endoscopy, radiological methods (Bichler 2006), FLOTAC
(a novel faecal egg count technique) (Knopp 2009; Glinz 2010),
and molecular tests using polymerase chain reaction (PCR) (Ten
Hove 2008; Oliveira 2010; Knopp 2011). However these tests
may be expensive or may require trained laboratory personnel and
an elaborate laboratory infrastructure.
Rationale
For improved mapping to ensure effective selective (or targeted)
treatment and for accurate data on treatment success with prazi-
quantel, appropriate diagnostic tests are urgently required. When
a test for diagnosing schistosomiasis is considered, a test with
high sensitivity is paramount, especially when infection is being
monitored within a disease control programme. False-negative re-
sults lead to missed treatment and subsequently to more advanced
disease or, if occurring after praziquantel treatment, may lead to
overestimated cure rates and potentially undetected cases of praz-
iquantel resistance and the spread of the disease. High specificity
is also required, as unnecessary treatment due to false-positive re-
sults could reduce cost-effectiveness in current control programme
strategies through potentially inaccurate classification of preva-
lence levels or in future targeted treatment control programmes
(WHO/TDR 2006). On the other hand, a test for mapping of
disease (to get an estimation of disease prevalence in an endemic
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area) may not need sensitivity and specificity as high as those re-
quired for monitoring of disease.
There is currently no recommended gold standard for the detec-
tion of active schistosomiasis. However, because microscopy is the
most commonly used test in practice and is often used as the ref-
erence test in studies, we selected it for use as the reference stan-
dard within this review to detect S. haematobium and S. mansoni.
The primary concern with microscopy is the possibility of missing
infected cases (because of its low and varied sensitivity), especially
in areas with low intensity of infection. This means that truly in-
fected cases may be missed and misclassified as non-infected by
microscopy. Therefore when comparing an index test against mi-
croscopy, the number of false-positives (potentially true cases clas-
sified as positive by the index test and classified as negative by the
reference test) may be high, and the index test may present with
low specificity. Increasing the sensitivity of microscopy by tak-
ing multiple measurements may reduce the number of true cases
wrongly classified as non-infected by microscopy. An index test
compared against a more sensitive reference test (microscopy with
multiple measurements) may have higher specificity because the
number of false-positives will be low. Our review will therefore
also investigate the effect of the quality of the reference standard
on the sensitivity and specificity of the index tests being evaluated.
In this case, a test considered as a replacement for microscopy
should have comparable sensitivity or should be less costly,
portable, faster, and easier to use or interpret, and it should be
less demanding logistically. Point-of-care tests based on circulating
antigen detection and biochemical urine reagent strips in particu-
lar are being included (or developed) in disease control strategies,
as they are easy to use and interpret, require minimal laboratory
infrastructure, are cost-effective, reduce patient waiting time and
potentially therefore reduce loss to follow-up, and may have com-
parable or higher sensitivity to microscopy (Loubiere 2010). The
results of this review may guide policy makers on appropriate di-
agnostic tests to use and may help identify research gaps in diag-
nostic testing for schistosomiasis in endemic areas.
O B J E C T I V E S
With the goals of making recommendations and informing policy
makers on which tests to use and identifying research gaps, these
were our primary objectives:
• To obtain summary estimates of the diagnostic accuracy of
urine reagent strip tests for microhaematuria, proteinuria, and
leukocyturia in detecting active S. haematobium infection, with
microscopy of urine as the reference standard.
• To obtain summary estimates of the diagnostic accuracy of
circulating antigen tests-a urine POC circulating cathodic
antigen (CCA) test, a urine and serum CCA enzyme-linked
immunosorbent assay (ELISA) test, and a urine and serum
circulating anodic antigen (CAA) test-for detection of active
Schistosoma infection in geographical regions endemic for S.
mansoni or S. haematobium or both, with microscopy as the
reference standard.
• To compare the accuracy of the above index tests.
• To investigate potential sources of heterogeneity in the
diagnostic accuracy of the tests listed above.
Secondary objectives
To investigate whether age and gender of participants, positivity
thresholds, prevalence of infection, intensity of infection, quality
of the reference standard, effects of praziquantel treatment, infec-
tion stage, mixed infections, and the methodological quality of
included studies can explain observed heterogeneity in estimates
of test accuracy.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included primary observational studies that compared the re-
sults of one ormore of the index tests versus the reference standard.
These studies could be cross-sectional in design, cohort studies,
or diagnostic case-control studies with cases and controls sampled
from the same patient population.
We included studies that provide participant data. Only studies in
which true-positives (TPs), true-negatives (TNs), false-positives
(FPs), and false-negatives (FNs) were reported or could be ex-
tracted from the data were included.
We excluded case-control studies with healthy controls, controls
from non-endemic areas, or controls with alternative diagnoses
(patients with diseases similar to schistosomiasis), as specificity
may be overestimated (Rutjes 2005). False-positive test resultsmay
occur when an alternative disease produces the same pathophys-
iological changes as the target condition. We also excluded stud-
ies that enrolled only participants with proven schistosomiasis, as
sensitivity may be overestimated.
Participants
Participants had to be individuals residing in regions where S.
haematobium and S. mansoni infections were endemic. We ex-
cluded articles that studied travelers originating fromnon-endemic
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countries, as they were typically screened with other tests such as
antibody tests.
Index tests
We included studies that evaluated the following tests.
Urine reagent strip tests
A urine reagent strip test is a biochemical semiquantitative test. It
is regarded as an indirect indicator of S. haematobium infection or
morbidity, as it detects microhaematuria, proteinuria, or leukocy-
turia (white blood cells in urine) that can develop as a consequence
of schistosomal infection (Doehring 1985b;Doehring 1988). This
test is cheap and easy to use for rapid screening of urinary schis-
tosomiasis (Feldmeier 1993; Gryseels 2006; Gryseels 2012).
The results of urine reagent tests used to measure haematuria are
scored as 0 (negative), trace-positive (tr), 1+ (5 to 10 erythrocytes/
µL), 2++ (10 to 50 erythrocytes/µL), or 3+++ (50 to 250 ery-
throcytes/µL). For proteinuria, results are scored as 0 (negative),
trace-positive (tr), 1+ (30 mg protein/dL), 2++ (100 mg protein/
dL), or 3+++ (500 mg protein/dL) (Murare 1987).
Antigen tests
Antigen tests are based on detection of schistosome antigens in
the serum and urine of individuals (Gryseels 2006; WHO/TDR
2006; Gryseels 2012). The main circulating antigens are adult
worm gut-associated circulating antigens, and CAA and CCA are
the main focus of research.
The CCA dipstick is scored according to test band reaction inten-
sity as negative (-), trace-positive (tr), single-positive (+), double-
positive (++), and triple-positive (+++) (Stothard 2006). ELISA
results are continuous, and positivity thresholds may vary. To es-
timate the accuracy of ELISA tests, ELISA must have been evalu-
ated against the reference standard only.
Target conditions
Active infection with S. haematobium.
Active infection with S. mansoni.
Reference standards
S. haematobium
For diagnosis of S. haematobium infection, the reference standard
is microscopy of urine for examination of schistosome eggs. To in-
crease sensitivity, urine samples can be concentrated by sedimen-
tation, filtration, or centrifugation techniques (Gryseels 2006), or
more samples can be examined (Feldmeier 1993). We therefore
included studies that use all of these concentration techniques, and
to estimate the effect of the quality of the reference standard, we
accepted studies usingmicroscopy on a single urine sample (lower-
quality reference standard) and studies performing microscopy on
multiple urine samples (higher-quality reference standard).
S. mansoni
For diagnosis of S. mansoni infection, microscopic examination
of schistosome eggs in stool is the reference standard. Sensitivity
is increased by preparing a faecal thick smear using the Kato-
Katz (KK)method (Gryseels 2006) or by examining multiple stool
samples (Feldmeier 1993). To estimate the effect of the quality of
the reference standard, we accepted studies using microscopy on a
single stool sample (lower-quality reference standard) and studies
performing microscopy on multiple stool samples (higher-quality
reference standard).
It is important to note that some regions experience mixed infec-
tions of S. haematobium and S. mansoni. In such situations, mi-
croscopy of both stool and urine samples must be carried out to
confirm infection.
Search methods for identification of studies
Electronic searches
We searched the electronic databasesMEDLINE,EMBASE,BIO-
SIS, MEDION, and HTA (Health Technology Assessment). The
MEDLINE search strategy is outlined in Appendix 3. We fur-
ther translated the MEDLINE search to EMBASE and BIOSIS
databases to identify additional records. To avoid missing studies,
we did not use a diagnostic search filter.We performed the searches
on 12 January 2012 and repeated them on 16 November 2012,
29 August 2013, and 30 June 2014.
Searching other resources
We looked through reference lists of relevant reviews and stud-
ies and websites of the World Health Organization (WHO), the
Schistosomiasis Control Initiative (SCI), and the Schistosomiasis
Consortium for Operational Research and Evaluation (SCORE).
When possible, we contacted study authors to request extra infor-
mation.
Data collection and analysis
Selection of studies
Two independent review authors first looked through titles and
abstracts to identify potentially eligible studies. Full-text articles of
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these studies were obtained and assessed for study eligibility by two
independent review authors using the predefined inclusion and
exclusion criteria. Disagreements were resolved through discussion
and by consultation with a third review author when necessary.
Data extraction and management
Two independent review authors extracted data onto a data ex-
traction form.
The following data were extracted.
• Study authors, publication year, and journal.
• Study design.
• Study participants-age, sex.
• Prevalence of schistosomiasis.
• Treatment status of participants with praziquantel-
treatment status before study or post treatment.
• Reference standard (microscopy), including number of
samples per individual and exact volume of stool/urine examined.
• Index tests-urine and serum circulating antigen tests (CCA
and CAA) and urine reagent strips.
• Urine reagent strips-signs measured (microhaematuria,
proteinuria, leukocyturia).
• Sample preparation techniques-time of day urine/stool
sample was taken, intensity of infection-egg counts in urine and
stool by microscopy.
• Presence of missing or unavailable test results.
• Numbers of TPs, FNs, FPs, and FNs.
Assessment of methodological quality
We used the Quality Assessment of Diagnostic Accuracy Stud-
ies (QUADAS-2) tool to assess risk of bias and concerns for ap-
plicability of the included studies (Whiting 2011) (Appendix 4).
Disagreements were resolved through consensus or by consulta-
tion with a third review author. We extracted data using signalling
questions and scored for risk of bias and concerns for applicability
under the four main domains: participant selection, index test,
reference standard, and participant flow.
Statistical analysis and data synthesis
Comparisons of index test versus the reference standard
We analyzed data for the two target conditions (S. haematobium
andS.mansoni) separately.Only one included study (Ashton 2011)
evaluated the ability of a test to detect S. haematobium and/orS.
mansoni in an area of mixed infection.
Among studies reporting sufficient data for calculating sensitivity
and specificity, we plotted their sensitivity and specificity in both
forest plots and receiver operating characteristic (ROC) space us-
ing the software ReviewManager 5.2. We performed a meta-anal-
ysis using the statistical software SAS version 9.2 for test types that
had sufficient data points (four or more data points) to be pooled
by the statistical models and those that did not demonstrate sub-
stantial heterogeneity in ROC space (Macaskill 2010). These tests
included the reagent strip for microhaematuria, the reagent strip
for proteinuria, the reagent strip for leukocyturia, the CCA POC
test for S. haematobium, and the CCA POC test for S. mansoni.
The statistical model selected to perform the overall meta-analysis
depended on the variability of the positivity thresholds, as dis-
cussed below. Data for urine reagent strips and urine CCA POC
tests were ordinal. These tests are typically scored as 0, trace, 1+,
2+, and 3+, or as 0, 1+, 2+, and 3+.
When data from a test hadmultiple thresholds, we used the hierar-
chical summary receiver operating characteristic model (HSROC)
to perform the overall meta-analysis. This model estimates the un-
derlying ROC curve, which describes how sensitivity and speci-
ficity of the included studies trade off with each other as thresholds
vary. It allows for variation in the parameters of accuracy, thresh-
olds between studies, and the shape of the underlying ROC curve
(Rutter 2001; Macaskill 2010). Because this method models sen-
sitivity and specificity indirectly, we calculated average sensitivities
and average specificities from the output of the model.
When data from a test had one or a common threshold, we used
the bivariate random-effects model to perform the overall meta-
analysis. This method models sensitivity and specificity directly at
a common threshold (Reitsma 2005; Macaskill 2010).
We included all studies in the overall meta-analysis, whether or
not a positivity threshold was included. We assumed that differ-
ent thresholds were used for the studies that did not report their
thresholds, and we used theHSROCmodel to perform the overall
meta-analysis. For urine reagent strips for microhaematuria and
proteinuria, many studies did not report a positivity threshold (n =
41 for microhaematuria and n = 25 for proteinuria). Some studies
(n = 2) provided data points at both thresholds of trace and +1.
When data points were provided at both thresholds, we selected
the data point at threshold trace for the overall analysis; we se-
lected the first stipulated positivity threshold. Leukocyturia had
five overall data points, with four data points at threshold trace
and one at +1. The CCA POC for S. haematobium had four overall
data points, with two at threshold trace and two at +1.
All studies evaluating CCA POC for S. mansoni reported positiv-
ity thresholds; five provided data points at both thresholds trace
and +1. When data points were provided at both thresholds, we
selected the data point at threshold trace for the overall analysis;
we selected the first stipulated positivity threshold. The overall
analysis therefore contained 15 data points with threshold≥ trace,
for which we used the bivariate model for meta-analysis.
Comparisons of index tests
We compared the accuracy of the reagent strips for microhaema-
turia in detectingS. haematobium versus the accuracy of the reagent
strips for proteinuria.These were the only tests with sufficient data
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to enable comparisons between different types of tests. Tests were
compared by adding the co-variate test type to the HSROCmodel
and allowing this to have an effect on the accuracy, threshold, and
shape parameters. We performed indirect comparisons and direct
comparisons; in the latter, we included only studies that applied
both index tests in the same individuals.
Investigations of heterogeneity
We investigated heterogeneity by examining the forest plots and
statistically by including co-variates in the HSROC or bivariate
model, by conducting subgroup analysis, and by performing sen-
sitivity analysis. In the HSROC model, we investigated whether
these co-variates affect the parameters of this model-accuracy,
threshold, and shape-whereas in the bivariate model, we investi-
gated whether these co-variates affect sensitivity and specificity.
We did not investigate the effects of infection stage and mixed
infection caused by poor reporting and insufficient data for these
items.
We investigated the following sources of heterogeneity: quality of
the reference standard, positivity threshold, age, gender (propor-
tion of female participation), intensity of infection, prevalence of
infection, effect of praziquantel treatment, and QUADAS-2 risk
of bias domains. Of these, the co-variates gender (proportion of
female participation) and prevalence of infection were analyzed as
a continuous co-variate. The rest were analyzed as categorical co-
variates.
We classified studies that used single-measurement microscopy
(one stool and/or one slide or smear) and those that did not report
how the reference standard was conducted as using lower-quality
reference standards because single measurements are more likely
to miss diseased individuals. We assumed that studies that used
multiple measurements of microscopy were likely to report this,
given the relevance of this additional effort. Reference standards
that used multiple urine or stool samples or multiple slides or
smears were classified as higher-quality reference standards.
For the age co-variate, many mixed adult/children studies did not
state the proportions of adults or children. Some did not state the
age of participants. As accuracy data were not provided for age
subgroups in most studies, we dichotomized the age co-variate
into the groups ’all ages’ and ’children only’. We assumed that
studies that did not state the age had included participants of all
ages.
Because the proportions of female and male participants were
poorly reported at the test level and at the level of the 2 × 2 tables,
we analyzed the co-variate of gender as a continuous variable at the
study level. For this co-variate, gender indicated the proportion
of female participation. We focused on females because gender
may influence accuracy estimates through factors associated with
females, such as menstruation and genitourinary tract infection
(Hall 1999; French 2007; Brooker 2009).
The World Health Organization (WHO) recommendations (
WHO 2002) categorize intensity of infection for S. haematobium
as follows: < 50 eggs/10 mL (light) and ≥ 50 eggs/10 mL (heavy)
and intensity of S. mansoni as follows: 1 to 99 eggs per gram (epg)
(light), 100 to 399 epg (moderate), and≥ 400 epg (heavy). In our
review, the intensity of infection was reported in different ways
(arithmeticmean or range of infection, or geometricmean or range
of infection, or proportions of participants with light/moderate/
heavy infection) and for most included studies was not reported
at all (63% and 65% for microhaematuria and proteinuria, re-
spectively). We used the reported estimates of mean (arithmetic/
geometric) or median intensity of infection to classify our studies
according to WHO recommendations. We classified as unclear
studies that reported only proportions of participants with light/
moderate/heavy infections or did not report estimates of intensity
of infection.
We examined the effects of treatment with praziquantel on the
sensitivity and specificity of the testtype microhaematuria because
it was the only test with sufficient data to investigate this. Nine
studies provided data on praziquantel treatment; seven were fol-
low-up studies with praziquantel given at variable intervals (King
1988_a (one year), NGoran 1989 (one month), Kitange 1993
(one year), Lengeler 1993 (one month), Shaw 1998 (six weeks),
Magnussen 2001 (one year), French 2007 (one year)), and two in-
dicated that praziquantel had been given before the baseline study
was performed (Abdel-Wahab 1992 (two years), Bogoch 2012
(two years)).Whenmultiple follow-up studies were performed, we
selected data for the first follow-up evaluation (Shaw 1998; French
2007). However, pooling of results of all studies with varying time
intervals would likely introduce a lot of heterogeneity, bias our
summary estimates, and lead to overestimates of sensitivity, be-
cause studies with long time intervals were likely to have a greater
number of participants reinfected compared with studies done at
shorter time intervals. We opted to present estimates of sensitivity
and specificity of individual studies evaluating the performance of
microhaematuria post treatment in the ROC space.
We added the following co-variates one by one to the HSROC
model for microhaematuria and proteinuria and to the bivariate
model for CCA POC for S. mansoni: quality of the reference stan-
dard, age, gender, and prevalence of infection. We then performed
a subgroup analysis for the co-variates-quality of the reference stan-
dard, age, positivity threshold, and intensity of infection-for all
three index tests.
Sensitivity analyses
We performed a sensitivity analysis to check the robustness of re-
sults when filtration was used as a concentration for urine mi-
croscopy for S. haematobium, and to estimate sensitivity and speci-
ficity for studies with low risk of bias according to the QUADAS
domains, along with participant selection, participant flow, and
the reference standard.
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Assessment of reporting bias
We did not assess reporting bias. Methods of assessing reporting
bias for diagnostic accuracy studies are still being refined. For in-
stance, theDeeks test, a test that has been proposed for use in diag-
nostic accuracy studies, has low power to detect funnel plot asym-
metry, especially when a lot of heterogeneity is present (Macaskill
2010). The studies included in our review showed a lot of het-
erogeneity; therefore assessments for reporting bias may not yield
conclusive results.
R E S U L T S
Results of the search
Our search yielded 17,477 hits. After the titles and abstracts were
screened, 152 full texts were retrieved, and after full texts were
assessed, 90 articles were deemed suitable for inclusion; 62 were
excluded. One study author whom we contacted responded to
our request for information, but the data submitted did not meet
our eligibility criteria. No additional eligible studies were found
through additional searches. This review contains results derived
from 90 articles. The search results can be seen in Figure 1.
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Figure 1. Study flow diagram.* Reasons for exclusion can be found in the table of Characteristics of
excluded studies.
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Included studies
Details of included studies can be found in the Characteristics of
included studies table.We included 90 studies containing 197,411
participants. Of these included studies, 88 were carried out in
Africa, one in South America (Surinam), and one in Asia (Yemen).
Only one study was conducted in a hospital setting (antenatal
clinic, outpatient setting). The other tests were performed in a
field setting (village/school/military camp). S. haematobium was
evaluated in most studies (n = 74); 16 evaluated S. mansoni. One
study evaluated both species. Eighty studies reported the age of
study participants; most of these were conducted in children (n =
50; 62.5%). Median prevalence of S. haematobium infection was
41% (range 1% to 89%), and that of S. mansoni infection was
36% (range 8% to 95%). Median female participation was 50%
(Q1 46; Q3 53) for studies that reported gender (n = 46; 51%).
Most of the included studies (n = 73; 81%) did not report on
the status of praziquantel treatment in the study setting before
the baseline study was performed. Eighty-one studies used a cross-
sectional design; six were cohort studies (longitudinal studies with
follow-up), and three were case-control studies with controls from
the same population (nested case-control studies). We included 84
English studies and six French studies. One study (Colley 2013),
which was retrieved through an updated search, provided recent
data for studies retrieved previously (Coulibaly 2011; Shane 2011;
Tchuente 2012). In this case, we gathered data for the 2 × 2 tables
from the most recent publication (Colley 2013).
Excluded studies
Full details of excluded studies can be found in the Characteristics
of excluded studies table. We excluded 62 articles after reading the
full texts. We excluded 17 case-control studies with healthy con-
trols or with controls from non-endemic areas of schistosomiasis.
We could not extract data from 2 × 2 tables for 16 studies. Twelve
studies were not test accuracy studies, and four studies enrolled
only patients proven to have schistosomiasis. Six studies used ref-
erence standards other than microscopy, four studies used other
index tests to diagnose schistosomiasis that did not fulfil our inclu-
sion criteria, and three studies performed similar tests on the same
population as those reported by other already included studies.
Methodological quality of included studies
Figure 2 and Appendix 5 show results of the quality appraisal of
the 60 included studies. Using the QUADAS-2 tool, we evaluated
these studies for risk of bias in the following domains: participant
selection, index test, reference standard, and participant flow. In
general, poor reporting of quality items hindered our evaluation
of quality. We therefore rated the risk of bias for these domains
largely as unclear. In the participant selection domain, about 75%
of studies were rated as having unclear risk of bias. For index tests,
unclear risk of bias ranged from80% to about 98% (about 98% for
reagent strips for microhaematuria, about 95% for reagent strips
for proteinuria, and about 80% for CCA POC testing). None of
the studies had high risk of bias in the index test domain. For the
reference standard, about 50% of the studies had high risk of bias,
whereas the other half had unclear risk of bias. For the participant
flow domain, about 75% of the studies had low risk of bias, and
the remaining studies had unclear risk. Concerns for applicability
for all four domains were predominantly low.
Figure 2. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies.
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Findings
A summary of the main findings can be found in Summary of
findings 1 and Summary of findings 2. Below we present in detail
the overall findings for each index test.
Urine reagent strips
For microhaematuria
A total of 74 evaluations of the reagent strip for microhaematuria
were performedwith a total of 102,447 individuals. All evaluations
were conducted in Africa. Median prevalence of S. haematobium
was 42% (range 1% to 87%), and median female participation
was 49% (Q1 49; Q3 53). Most of these evaluations were con-
ducted with a lower-quality reference standard of only one slide/
person (n = 63; 85%), and most evaluations were carried out in
mixed populations of adults and children (n = 40; 54%). These
evaluations were described in articles published between the years
1979 and 2014; a large proportion (n = 43; 58%) were published
between 1979 and 1999. Over these four decades, no clear pattern
was evident for effects of year of study on sensitivity and specificity
of microhaematuria (see forest plot in Appendix 6). However, the
forest plot shows greater heterogeneity for sensitivity compared
with specificity.
A large range of test brands were used to estimate the sensitivity
and specificity of microhaematuria, as shown in Appendix 7. Most
evaluations (n = 25; 34%) were performed with the brand from
the manufacturer Ames.
The forest plot (Figure 3) and the HSROC curve (Figure 4) for
the reagent strip for microhaematuria reveal heterogeneity for es-
timates of both sensitivity and specificity.
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Figure 3. Forest plot of sensitivity and specificity of the urine reagent strip for microhaematuria.Squares
represent sensitivity and specificity of one study, the black line its confidence interval.
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Figure 4. Summary ROC plot of sensitivity versus specificity of the urine reagent strip for
microhaematuria.The size of the points is proportional to the study sample size. The solid line shows the
summary ROC curve.
Meta-analytical sensitivity and specificity (95% confidence inter-
val (CI)) of data at mixed thresholds were 75% (71% to 79%) and
87% (84% to 90%).
For proteinuria
A total of 46 evaluations of the reagent strip for proteinuria were
performed with a total of 82,113 individuals. All evaluations were
conducted in Africa. Median prevalence of S. haematobium was
15Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
51% (range 4% to 89%), and median female participation was
50% (Q1 46; Q3 53). Most of these evaluations were conducted
with a lower-quality reference standard (n = 36; 78%), and most
were carried out in mixed populations of adults and children (n =
28; 61%). These evaluations were described in articles published
between the years 1979 and 2014; the largest proportion (n =
27; 59%) were published before the year 2000. Over these four
decades, no clear pattern was evident for effects of year of study
on sensitivity and specificity of proteinuria (see forest plot in
Appendix 8).
A large range of test brands were used to estimate the sensitivity
and specificity of proteinuria, as shown in Appendix 9. Most eval-
uations (n = 17; 37%) were performed using the brand from the
manufacturer Ames.
The forest plot (Figure 5) and the HSROC plot (Figure 6) for
the reagent strip for proteinuria reveal greater heterogeneity for
estimates of sensitivity than specificity. Meta-analytical sensitivity
and specificity (95% CI) of data at mixed thresholds were 61%
(53% to 68%) and 82% (77% to 88%).
Figure 5. Forest plot of sensitivity and specificity of the urine reagent strip for proteinuria.Squares
represent the sensitivity and specificity of one study, the black line its confidence interval.
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Figure 6. Summary ROC plot of sensitivity versus specificity of the urine reagent strip for proteinuria.The
size of the points is proportional to the study sample size. The solid line shows the summary ROC curve.
For leukocyturia
A total of five evaluations of the reagent strip for leukocyturia
were performed with data from four publications and a total of
1532 individuals. Of these evaluations, two were carried out with
a higher-quality reference standard (40%). Median prevalence of
S. haematobium was 34% (range 4% to 77%), and median female
participation was 100% (Q1 68; Q3 100). All evaluations except
one were conducted in Africa in mixed populations of adults and
children. These evaluations were described in articles published
between the years 1992 and 2000; most (n = 3) were published
before the year 2000. Two different test brands were evaluated.
Most evaluations (n = 3; 60%) were done using the Nephur-test
from Boehringer Mannheim.
The forest plot (Figure 7) and the HSROC plot (Figure 8) for
the reagent strip for leukocyturia reveal greater heterogeneity for
estimates of specificity than sensitivity. The ROC plot also reveals
poor accuracy of the test, as most study points lie close to the
diagonal line. Meta-analytical sensitivity and specificity (95% CI)
of data at mixed thresholds were 58% (44% to 71%) and 61%
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(34% to 88%).
Figure 7. Forest plot of sensitivity and specificity of the urine reagent strip for leukocyturia.Squares
represent the sensitivity and specificity of one study, the black line its confidence interval.
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Figure 8. Summary ROC plot of sensitivity versus specificity of the urine reagent strip for leukocyturia.The
size of the points is proportional to the study sample size. The solid line shows the summary ROC curve.
Urine CCA POC test
For S. haematobium
A total of four evaluations of the CCA POC test for S. haema-
tobium were performed on data derived from four publications
with a total population of 901 individuals. Median prevalence of
S. haematobium was 40% (range 31% to 48%), and median fe-
male participation was 47% (Q1 40; Q3 51). Most of these eval-
uations were conducted with a lower-quality reference standard
(n = 3; 75%). All evaluations were conducted in Africa. All eval-
uations included data from children only. These evaluations were
described in articles published between the years 2008 and 2011.
Four different test brands were evaluated.
Forest plots (Figure 9) andROCplots (Figure 10) for this test reveal
a high degree of heterogeneity for estimates of both sensitivity and
specificity. The ROC plot also reveals poor accuracy of the test,
as the study points lie close to the diagonal line. Meta-analytical
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sensitivity and specificity (95% CI) of data at mixed thresholds
were 39% (6% to 73%) and 78% (55% to 100%).
Figure 9. Forest plot of the sensitivity and specificity of the urine CCA POC test for S.
haematobium.Squares represent the sensitivity and specificity of one study, the black line its confidence
interval.
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Figure 10. Summary ROC plot of sensitivity versus specificity of the urine CCA POC test for S.
haematobium.The size of the points is proportional to the study sample size. The solid line shows the
summary ROC curve.
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For S. mansoni
A total of 15 evaluations of the CCA POC test for S. mansoni
were performed on data derived from 13 publications with a total
population of 6091 individuals. Median prevalence of S. mansoni
was 36% (range 8% to 68%), and median female participation
was 49% (Q1 48; Q3 51). Most of these evaluations were con-
ducted with a lower-quality reference standard (n = 10; 67%). All
evaluations were conducted in Africa, and all except one included
data from children only. These 15 evaluations were described in
articles published between the years 2007 and 2014. Two different
test brands were evaluated: Rapid Diagnostic Tests from Pretoria
South Africa and Schistosomiasis One Step Test from EVL Hol-
land, as shown in Appendix 10. Most evaluations (n = 9) were
performed using the Rapid Diagnostic Tests from South Africa.
The forest plot for this test reveals greater heterogeneity for es-
timates of specificity versus estimates of sensitivity (Figure 11).
Meta-analytical sensitivity and specificity (95% CI) of data at a
threshold ≥ trace positive were 89% (86% to 92%) and 55%
(46% to 65%) (Figure 12).
Figure 11. Forest plot of sensitivity and specificity of the urine CCA POC test for S. mansoni.Squares
represent the sensitivity and specificity of one study, the black line its confidence interval. Colley 2013 was a
study that included data for 5 studies (done in different countries). Some of the studies had been published
earlier (Coulibaly 2011, Erko 2013, Shane 2011, Tchuente 2012). In this case, we used data from Colley 2013,
which provided the most recent and updated data.
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Figure 12. Summary ROC plot of sensitivity versus specificity of the urine CCA POC test for S.
mansoni.The size of the points is proportional to the study sample size. The thick black point shows the
average value for sensitivity and specificity. The inner ellipse around the black spot represents the 95%
confidence regions around the summary estimates. The outer ellipse represents the prediction region.
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For mixed infection
One study assessed the capability of the POC test to detect schis-
tosomiasis in an area of mixed S. haematobium and S. mansoni
infection. This evaluation was conducted in Africa (Southern Su-
dan) in children only and was published in 2011. The brand used
was Rapid Diagnostic Tests from Pretoria, South Africa. The sen-
sitivity of the test was 66%, and the specificity was 79%. Nometa-
analysis was performed for this test because of insufficient data.
CAA ELISA test
Serum
A total of five evaluations of the serum CAA test for S. mansoni
were performed on data derived from four publications (total pop-
ulation 1583, years of publication 1995 to 1998). Median preva-
lence of S. mansoni was 93% (range 28% to 96%), and median
female participation was 49% (Q1 49; Q3 51). All of these eval-
uations were conducted using relatively higher-quality reference
standards (n = 5; 100%). All were in-house assays, and one study
involved only children. Sensitivity of the serum CAA ELISA for
S. mansoni ranged from 47% to 94%, and specificity ranged from
8% to 100% (Appendix 11). The ROC plot (Appendix 12) re-
veals a lot of scatter of the estimates of sensitivity and specificity
provided by the included studies.
A total of three evaluations of the serum CAA test forS. haema-
tobium were performed on data derived from three publications
(total population 990, years of publication 1995 to 1999). Me-
dian prevalence of S. haematobium was 38% (range 18% to 57%).
Only one study provided data on gender proportions (female par-
ticipation was 54%). Two of the three evaluations were conducted
using a higher-quality reference standard (67%). All were in-house
assays, and all were carried out in mixed populations of adults and
children. Sensitivity of the serum CAA test for S. haematobium
ranged from 55% to 97%, and specificity ranged from 24% to
57% (Appendix 13; Appendix 14).
Urine
Only one evaluation of the urine CAA test for S. mansoni was
performed on data derived from one publication (total population
204, year of publication 1995).. This was an in-house assay and
was done on data obtained from a mixed population of adults and
children. Sensitivity of this test was 10%, and specificity was 99%.
Only one evaluation of the urine CAA test for S. haematobiumwas
performed on data derived from one publication (total population
370, year of publication 1999). This in-house assay was performed
on data obtained from a mixed population of adults and children.
Sensitivity of this test was 16%, and specificity was 94%.
CCA ELISA test
Serum
Two evaluations of the urine CCA test for S. mansoni were per-
formed on data derived from two publications (total population
569, year of publication 1995). Both were in-house assays per-
formed on data obtained from a mixed population of adults and
children. Sensitivity of this test ranged from 36% to 85%, and
specificity was 50% to 93% (Appendix 15).
Only one evaluation of the urine CCA test for S. haematobiumwas
performed on data derived from one publication (total population
370, year of publication 1999). This in-house assay was performed
on data obtained from a mixed population of adults and children.
Sensitivity of this test was 3%, and specificity was 90%.
Urine
Two evaluations of the urine CCA test for S. mansoni were per-
formed on data derived from two publications (total population
560, year of publication 1995). Both were in-house assays, and
neither involved children only. Sensitivity of this test ranged from
62% to 97%, and specificity from 27% to 84% (Appendix 16).
Only one evaluation of the urine CCA test for S. haematobiumwas
performed on data derived from one publication (total population
370, year of publication 1999). This in-house assay did not involve
children only. Sensitivity of this test was 78%, and specificity was
70%.
Comparisons of accuracy between reagent strips for
microhaematuria and proteinuria
Results of comparisons between microhaematuria and proteinuria
are outlined in the Summary of findings 1. We first compared ac-
curacy in all studies (indirect comparisons); we then limited the
comparison to paired studies (direct comparisons). No statistically
significant difference between the accuracy of microhaematuria
and that of proteinuria was observedwhen the tests were compared
in different populations using all studies (P = 0.25) (Figure 13).
This can be demonstrated in the ROC curve showing the curves
of tests as close together and crossing. The difference in accuracy
also was not statistically significant when the tests were directly
compared in the same individuals (P = 0.21) (Figure 14). A statis-
tically significant difference in the threshold parameter was noted
when the tests were compared in different populations using all
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studies (P < 0.0001), and when the tests were directly compared
in the same individuals (P = 0.0009). This could imply that one
test has a different operating threshold when compared with the
other, and although overall accuracy is not statistically significantly
different, sensitivity and specificity may be different under field
circumstances.
Figure 13. Summary ROC plot of sensitivity versus specificity showing the indirect comparison between
microhaematuria and proteinuria (all studies). The solid lines show the summary ROC curves.
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Figure 14. Summary ROC plot of sensitivity and specificity showing the direct comparison between
microhaematuria and proteinuria (paired studies). Study points of microhaematuria and proteinuria from the
same study are joined by a dotted line. The solid lines show the summary ROC curves.
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Investigations of heterogeneity
Co-variates in the models
The co-variates quality of reference standard, age, gender (% fe-
male participation), prevalence of infection, and intensity of infec-
tion were added to the HSROC model. We investigated whether
these co-variates affect the parameters of the HSROCmodel, that
is, accuracy, threshold, and shape.
For the reagent strip for microhaematuria, the co-variates age (P
= 0.002) and gender (% female participation) (P = 0.02) had
statistically significant effects only on the threshold parameter of
the HSROC model.
For the reagent strip for proteinuria, the co-variates quality of ref-
erence standard (P = 0.01) and prevalence of infection (P value
0.007) had statistically significant effects on the accuracy parame-
ter. Accuracy was higher with the higher-quality reference standard
and in settings with higher prevalence. Other co-variates did not
have a statistically significant effect on any of the other parameters
of the HSROC model.
For CCA POC used to detect S. mansoni, no co-variate had a
statistically significant effect on sensitivity or on specificity.
Subgroup analysis
Table 1, Table 2, and Table 3 outline the results of subgroup anal-
yses on the tests microhaematuria, proteinuria, and CCA POC for
S. mansoni. When these tests were evaluated against the higher-
quality reference standard (ie when multiple samples were ana-
lyzed), sensitivity was lower for microhaematuria (71% vs 76%)
and proteinuria (49% vs 68%) than with a lower-quality reference
standard. Specificity of these tests was lower for microhaematuria
(85% vs 87%) but higher for proteinuria (83% vs 78%). In con-
trast, sensitivity was similar (88%) and specificity was higher for
the CCA POC test for S. mansoni (66% vs 55%) when measured
against a higher-quality reference standard in comparison with a
lower-quality reference standard.
Microhaematuria and proteinuria had higher sensitivity (77% vs
73% and 67% vs 56%) in children than in mixed populations of
adults and children. Specificity was higher for microhaematuria
(91% vs 82%) but was comparable for proteinuria (81% vs 82%)
in children compared with mixed populations of adults and chil-
dren. All except one study of CCA POC for S. mansoni were car-
ried out with children. At a positivity threshold≥ 1, sensitivity of
CCA POC for S. mansoniwas lower (72% vs 89%) and specificity
higher (85% vs 55%) than at a positivity threshold of trace posi-
tive. In the light-intensity subgroup, sensitivity was slightly lower
for microhaematuria (73% vs 75%) and specificity was slightly
higher (88% vs 87%) compared with results of the overall analy-
sis. In contrast, sensitivity (60% vs 61%) and specificity (83% vs
82%) for proteinuria were comparable. Data were insufficient to
permit estimation of the sensitivity and specificity of CCA POC
for S. mansoni in light-intensity settings.
The forest plot (Figure 15) and the ROC plot (Figure 16) demon-
strating sensitivity and specificity for microhaematuria after praz-
iquantel treatment show a lot of variation in the estimates (pre-
dominantly for sensitivity) of the individual studies.
Figure 15. Forest plot of sensitivity and specificity of the urine reagent strip for microhaematuria for studies
done after treatment with praziquantel.Squares represent the sensitivity and specificity of one study, the black
line its confidence interval.
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Figure 16. Summary ROC plot of sensitivity and specificity of the urine reagent strip for microhaematuria
for studies done after treatment with praziquantel.The size of the points is proportional to the study sample
size
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Sensitivity analysis
For microhaematuria, when the analysis was limited to studies
that used filtration only as the concentration method for urine mi-
croscopy, sensitivity (73% (69% to 78%) vs 76% (72% to 80%))
was lower and specificity was comparable (86% (82% to 89%) vs
86% (82% to 89%)) with those produced by the overall analysis.
For proteinuria, when the analysis was limited to studies that used
filtration only as the concentration method for urine microscopy,
sensitivity was comparable (62% (52% to 71%) vs 61% (53% to
69%) and specificity was lower (80% (73% to 86%) than those
produced by the overall analysis (83% (77% to 88%)) (Table 1;
Table 2; Table 3).
Sensitivities and specificities of microhaematuria were compara-
ble when analysis was limited to studies with low risk of bias for
the participant flow domain. Sensitivity of proteinuria was higher
when limited to studies with low risk of bias for the participant
selection domain (64%) and the participant flow domain (67%).
Specificity on the other hand was comparable for these two do-
mains. Sensitivity and specificity of CCA POC for S. mansoni
were comparable when limited to studies with low risk of bias
for the participant flow domain (Table 1; Table 2; Table 3). Data
were insufficient to allow estimation of sensitivity and specificity
for studies with low risk of bias in the other domains-reference
standard and participant selection-for the CCA POC test for S.
mansoni.
As part of post hoc analyses, we noted that three evaluations
showed substantial heterogeneity for the tests microhaematuria
(Aryeetey 2000; sensitivity 55%, specificity 36%), proteinuria
(Aryeetey 2000; sensitivity 38%, specificity 11%), and CCA POC
for S.mansoni (Standley 2010; sensitivity 99%, specificity 19%).
We excluded these evaluations in sensitivity analyses for the respec-
tive tests and found the following results. Results for microhaema-
turia (sensitivity 75%, specificity 87%) and proteinuria (sensitivity
61%, specificity 82%) were similar to those of the overall analysis.
For CCA POC for S. mansoni, sensitivity was comparable (88% vs
89%) and specificity was slightly higher (58% vs 55%) compared
with those of the overall analysis.
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Summary of findings
What is the diagnostic accuracy of circulating antigen tests and biochemical urine reagent strips in detecting S. haematobium infection?
Patients/Population People residing in areas endemic for S. haematobium infection (74 out of 90 studies)
Prior treatment with praz-
iquantel before baseline
study
Yes (6 studies), No (11 studies), Unclear (57 studies)
Prior testing None
Settings Field settings (villages and schools) and 1 outpatient clinic in Africa
Index tests Circulating cathodic antigen test (CCA)
Circulating anodic antigen test (CAA)a
Urine reagent strips to detect microhaematuria, proteinuria, and leukocyturia
Reference standard Urine microscopy
Importance These tests are being used as replacements for conventional microscopy in disease control programmes for schistosomiasis, as they are rapid, are easier to use
and interpret, and may have comparable sensitivity to microscopy. As control programmes gain impetus and infection intensities decrease, higher sensitivities
become a prerequisite for future diagnostics
Studies Cross-sectional (n = 62), cohort (n = 6), and case-control studies with controls from same population (n = 3)
Quality concerns Poor reporting of participant characteristics, index test and reference standard methods, and intensity of infection were common concerns. The risk of bias
assessment for most included studies was largely unclear for the QUADAS domains Patient Selection, Index Tests, and Reference Tests
Test types Number of evaluations Summary estimates
(95% CI)
In 1000 people tested
Infected cases
S. haematobium
Missed cases
(FNs)
False-
positives
(FPs)
All positives
(TPs + FPs)
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Biochemical urine
reagent strips
For microhaematuria 74 Sens = 75% (71% to
79%)
Spec = 87% (84% to
90%)
410 102 77 384
For proteinuria 46 Sens = 61% (53% to
68%)
Spec = 82% (77% to
88%)
410 160 106 356
For leukocyturia 5 Sens = 58% (44% to
71%)
Spec = 61% (34% to
88%)
410 172 230 468
Circulating cathodic
antigen test (CCA)
Urine POC test 4 Sens = 39% (6% to 73%)
Spec = 78% (55% to
100%)
410 250 94 254
Comparisons
Comparison Comparison type Number of evaluations
and differences in over-
all accuracy
Explanation
Microhaematuria vs pro-
teinuria
All studies 74 microhaematuria vs
proteinuria, difference in
accuracy (P = 0.25)
We found no evidence of
a statistically significant
difference in overall accu-
racy when microhaema-
turia and proteinuria are
carried out and compared
Proteinuria would be ex-
pected to miss 14% more
cases than microhaema-
turia
Proteinuria would be ex-
pected to falsely identify
5% more cases than mi-
crohaematuria
3
1
C
irc
u
la
tin
g
a
n
tig
e
n
te
sts
a
n
d
u
rin
e
re
a
g
e
n
t
strip
s
fo
r
d
ia
g
n
o
sis
o
f
a
c
tiv
e
sc
h
isto
so
m
ia
sis
in
e
n
d
e
m
ic
a
re
a
s
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
5
T
h
e
A
u
th
o
rs.
C
o
c
h
ra
n
e
D
a
ta
b
a
se
o
f
S
y
ste
m
a
tic
R
e
v
ie
w
s
p
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
o
n
b
e
h
a
lf
o
f
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
in different individuals
Paired studies
(tests done in the same
individuals)
44 microhaematuria vs
proteinuria, differences in
accuracy (P = 0.21)
We found no evidence of
a statistically significant
difference in overall accu-
racy when microhaema-
turia and proteinuria are
carried out and compared
in the same individuals
a Studies were insufficient to provide summary estimates for the CAA tests.
When the tests were evaluated against the higher-quality reference standard (ie when multiple samples were analyzed), sensitivity was
lower for microhaematuria (71% vs 76%) and proteinuria (49% vs 61%) in comparison with a lower-quality reference standard. The
specificity of these tests was comparable.
In light-intensity settings, sensitivity was slightly lower for microhaematuria (73% vs 76%) and specificity was slightly higher (88% vs
86%) compared with results of the overall analysis. In contrast, sensitivity (60% vs 61%) and specificity (83% vs 83%) for proteinuria
were comparable.
Microhaematuria and proteinuria had higher sensitivity (77% vs 73% and 67% vs 56%) in children than in mixed populations of adults
and children. Specificity was higher for microhaematuria (91% vs 82%) but specificity was comparable for proteinuria (81% vs 82%) in
children compared with mixed populations of adults and children.
For the effects of risk of bias, sensitivities and specificities of microhaematuria were comparable when limited to studies with low risk of
bias for the participant flow domain. Sensitivity of proteinuria was higher when limited to studies with low risk of bias for the participant
selection domain (64%) and the participant flow domain (67%). Specificity on the other hand was comparable for these 2 domains.
Abbreviations: TPs (true-positives), FPs (false-positives), FNs (false-negatives).
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What is the diagnostic accuracy of circulating antigen tests for S. mansoni infection?
Patients/Population People residing in areas endemic for S. mansoni infection (16 out of 90 studies)
Prior treatment with praz-
iquantel before baseline
study
Yes (1 study), No (5 studies), Unclear (10 studies)
Prior testing None
Settings Field settings (villages, schools, and military camp) in Africa and South America
Index tests Circulating cathodic antigen test (CCA)
Circulating anodic antigen test (CAA)a
Reference standard Stool microscopy
Importance These tests are being used as replacements for conventional microscopy in disease control programmes for schistosomiasis, as they are rapid, are easier to use
and interpret, and may have comparable sensitivity to microscopy. As control programmes gain impetus and infection intensities decrease, higher sensitivities
become a prerequisite for future diagnostics
Studies Cross-sectional studies
Quality concerns Poor reporting of participant characteristics, index test and reference standard methods, and intensity of infection were common concerns. The risk of bias
assessment for most included studies was largely unclear for the QUADAS domains Patient Selection, Index Tests, and Reference Tests
Test types Number of evaluations Summary
estimates
(95% CI)
In 1000 people tested
Infected cases
S. mansoni
Missed cases
(FNs)
False-positives
(FPs)
All
positives (TPs + FPs)
Circulating cathodic
antigen test (CCA)
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Urine POC test 15 Sens = 89% (86% to
92%); Spec = 55% (46%
to 65%)
360 40 288 608
a Studies were insufficient to provide summary estimates for CAA tests.
When measured against a higher-quality reference standard, sensitivity of CCA POC for S. mansoni was comparable (88% vs 88%) but
specificity was higher (66% vs 55%) than when measured against a lower-quality reference standard.
At a positivity threshold ≥ 1, sensitivity of CCA POC for S. mansoni was lower (72% vs 87%) and specificity higher (85% vs 61%) than
at a positivity threshold of trace-positive.
Data were insufficient to estimate the sensitivity of CCA POC for S. mansoni in light-intensity settings.
For the effects of risk of bias, sensitivity and specificity of CCA POC for S. mansoni were comparable when limited to studies with low
risk of bias for the participant flow domain.
Abbreviations: TPs (true-positives), FPs (false-positives), FNs (false-negatives).
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D I S C U S S I O N
Summary of main results
This review focused on analyzing the accuracy of urine reagent
strips for the diagnosis of S. haematobium and of circulating anti-
gen tests for the detection of S. haematobium and S. mansoni in-
fections. Microscopy was used as the reference standard, and 90
studies were found to fit our inclusion criteria; data from these
studies were used in this review. The main results, including av-
erage sensitivities and specificities for tests included in the meta-
analyses, are reported in Summary of findings 1 and Summary of
findings 2.
Most of the studies included in our overall meta-analyses used a
‘lower-quality reference test’: microhaematuria 81%, proteinuria
73%, leukocyturia 60%, circulating cathodic antigen point-of-
care (CCA POC) for S. haematobium 75%, and CCA POC for
S. mansoni 81%. This implies that infections missed by single-
sample microscopy may have increased the number of false-pos-
itives identified by the index tests, consequently leading to lower
estimates of specificity.
Our overall analyses suggest that among the tests used to detect
S. haematobium, the urine reagent strip for microhaematuria de-
tects the largest proportion of schistosome infections identified by
microscopy (sensitivity 75%); it also detects the largest propor-
tion of non-infections identified by microscopy (specificity 87%).
Proteinuria follows suit, with sensitivity of 61% and specificity of
82%.
The superior performance of microhaematuria over proteinuria
was not statistically significant when the comparison was per-
formed both indirectly (using all studies) and directly (using paired
studies) within the HSROC model. When measured against a
higher-quality reference standard (multiple measurements), mi-
crohaematuria had both lower sensitivity (71% vs 75%) and lower
specificity (85% vs 87%) than were seen with a lower-quality ref-
erence standard. Proteinuria on the other hand, when measured
against a higher-quality reference standard, had lower sensitivity
(49% vs 61%) and higher specificity (82% vs 78%) versus a lower-
quality reference standard. Increasing the sensitivity of microscopy
by taking multiple measurements may reduce the number of true
cases wrongly classified as non-infected by microscopy. An index
test compared against a more sensitive reference test (higher qual-
ity) may have higher specificity because the number of false-pos-
itives will be low. The lower specificity for microhaematuria may
be due in part to poor reporting of how the reference standard was
conducted in some studies.
Our results suggest that the urine reagent strip when used to de-
tect leukocyturia is limited by low sensitivity (58%) and specificity
(61%) and is not useful in practice. The low sensitivity for leuko-
cyturia could be explained by the variations inmorbidity caused by
S. haematobium. Not all infected people have leukocyturia; there-
fore the proportion of false-negatives is higher. The CCA POC
test has very low sensitivity (39%) to detect S. haematobium and
specificity of 78% and may not be suitable for mapping or estima-
tion of infection, because it misses very many infections identified
by microscopy.
The CCA POC test for S. mansoni detected a large proportion of
infections identified by microscopy (sensitivity 89%). However, it
also detected a lower proportion of the non-infected cases identi-
fied by microscopy (specificity 55%). The low specificity can be
explained by the fact that most studies in the overall analyses were
measured against a lower-quality reference standard. When com-
pared with a higher-quality reference standard, the CCA POC test
had comparable sensitivity (88%) but higher specificity (66%).
Arguably, if the reference standard had been even better, this speci-
ficity might have increased further.
As studies were insufficient, we were unable to generate summary
estimates for the circulating antigen enzyme-linked immunosor-
bent assay (ELISA) tests (CCA and circulating anodic antigen
(CAA)). Estimates of sensitivity and specificity from the included
studies evaluating these tests ranged widely.
Results of our assessment of risk of bias of the included studies
were largely unclear because of poor reporting of items in these
studies.
Application of the meta-analysis to a hypothetical
cohort
Summary of findings 1 and Summary of findings 2 apply the re-
sults of the meta-analyses to a hypothetical cohort of 1000 indi-
viduals suspected of having active S. haematobium and/or active
S. mansoni infection in a field setting. We illustrate the impact of
using microhaematuria, proteinuria, leukocyturia, and CCAPOC
for S. haematobium in a setting with a prevalence of S. haemato-
bium infection of 41%, and the impact of using CCA POC for
S. mansoni in a setting with a prevalence of S. mansoni infection
of 36%. These are the estimates of median prevalence of infection
obtained from all studies included in this review.
Delivery of population-based control programmes such as treat-
mentwith praziquantel requires knowledge of prevalence estimates
of schistosomal infections (Colley 2014). This helps the clinician
in determining whether mass drug treatment should be adminis-
tered in settings of very high prevalence, or targeted treatment in
settings of low prevalence. We have included descriptions of the
performance of these tests in estimating the prevalence (index test
positives (TP + FP)) of S. haematobium and S. mansoni infections.
S. haematobium infection
If the point estimates of the tests for S. haematobium are applied
to a hypothetical cohort of 1000 individuals suspected of having
active S. haematobium infection, among whom 410 actually have
the infection, the strip for microhaematuria would be expected to
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miss (102) and falsely identify (77) the least number of cases. This
test would identify 384 positive cases in total.
For the other tests (in increasing order of missed cases): The strip
for proteinuria would be expected to miss 160 cases and to falsely
identify 106 cases; proteinuria would be expected to miss 14%
more cases than microhaematuria and to falsely identify 5% more
cases than microhaematuria; leukocyturia would be expected to
miss 172 cases and to falsely identify 230 cases; and the CCA POC
test would be expected to miss 250 cases and to falsely identify
130 cases. In total, the strips for proteinuria, leukocyturia, and the
CCA POC test would identify 356, 468, and 254 positive cases,
respectively.
Overall, when infection ismapped, the prevalence ofmicrohaema-
turia would seem to be 38%-close to the true prevalence of 41%.
The prevalence of proteinuria would seem to be 36%, that of
leukocyturia 47%, and that of CCA POC 25%. In cases of mass
treatment, the ultimate consequences of these numbers would de-
pend on the minimal prevalence needed to start mass treatment.
S. mansoni infection
If the point estimates for the CCA POC test are applied to the
same hypothetical cohort of 1000 individuals suspected of having
active S. mansoni infection, among whom 360 actually have the
infection, the CCA POC test would be expected to miss 40 cases
and to falsely identify 288 cases. In total, the test would identify
608 positive cases (for an observed prevalence of 61%).
Comparison with other reports
The absence of a suitable gold standard for active schistosomiasis
is reflected in the existing literature, where different reference stan-
dards are used with subsequent variation in accuracy (especially
with specificity) of the index test (Koukounari 2009; Coulibaly
2011; Tchuente 2012; Colley 2013; Erko 2013; King 2013;Lodh
2013; Sousa-Figueiredo 2013).
A meta-analysis was recently published that assessed the accuracy
of urine reagent strips for microhaematuria against conventional
microscopy as a reference standard (King 2013). Unlike King’s re-
view, our review also estimated the accuracy of other urine reagent
strips for proteinuria and leukocyturia. To guide decision mak-
ing, it is important to show which of these tests fares better. Our
analyses suggest that microhaematuria has higher sensitivity than
proteinuria and leukocyturia.
Compared with results from King’s meta-analysis (King 2013),
our estimate of sensitivity for microhaematuria was lower (75%
vs 81%) but specificity was comparable (87% vs 89%). This dif-
ference may be attributed to the method of meta-analysis used.
King used the HSROC regression following a Bayesian Monte
Carlo Markov chain approach (Dendukuri 2012), and we used
the HSROC model recommended in the Cochrane Handbook for
Systematic Reviews of Interventions (Macaskill 2010). With regard
to sources of heterogeneity, some of our results are also compara-
ble with those of King 2013. For instance, King found through
multi-variable regression modelling that the urine heme dipstick
performed better in children than in mixed populations of adults
and children (Relative diagnostic odds ratio = 3.16). In our re-
view, we found that sensitivity and specificity were higher in stud-
ies on children compared with studies on mixed populations of
adults and children. We strongly confirm that this test is therefore
highly suitable for mass mapping of school-aged children in en-
demic areas. Again our analyses show that sensitivity of the urine
heme dipstick was slightly lower in settings of low intensity (73%)
compared with that of the overall estimate (75%). This finding
was similar to the findings of King, which showed that sensitivity
of the urine heme dipstick was lower in settings of lower infec-
tion intensity (65%) in the subgroup analysis than in the overall
analysis (81%). However it should be noted that our definition of
light intensity differed from that used by King. We selected the
more commonly used World Health Organization (WHO) rec-
ommended cutoff of < 50 eggs per 10 mL, whereas King defined
low intensity as ≤ 100 eggs/10 mL. This could explain in part
why our sensitivity estimates were higher than those of King in
settings of light intensity.
A key difference between our review and that of King 2013 con-
cerned the effects of treatment on the estimate of sensitivity of the
heme dipstick. In a subgroup of eight studies with mixed post-
treatment evaluations of one year (n = 6), six months (n = 1),
and one month (n = 1), King’s review produced a lower summary
estimate of sensitivity (72%) in the subgroup of treated popula-
tions as comparedwith the overall analysis (81%). King considered
treatment evaluations with praziquantel and metrifonate, whereas
we focused on studies that evaluated the effects of praziquantel
treatment, as this is the current drug of choice. Because studies
reported varied time intervals between treatment and retesting,
we opted not to pool the estimates of studies, as this would likely
produce biased overestimates of sensitivity and specificity. Stud-
ies with long time intervals were likely to include greater num-
bers of participants reinfected compared with studies carried out
at shorter time intervals, and their results may be confounded by
repeated treatments provided by national programmes.
A recently published multi-centre evaluation of CCA POC tests
done in five African countries (Colley 2013) recommended that
the CCA POC test for S. mansoni (evaluated with a positivity
threshold ≥ trace positive) was a sufficiently sensitive and spe-
cific tool for mapping intestinal schistosomiasis in moderate- to
high-prevalence areas, and therefore it was a viable alternative to
microscopy (Colley 2013). After acknowledging the absence of
a gold standard, this multi-centre study used latent class analysis
(modelling results from CCA POC, Kato-Katz, and PCR) to gen-
erate an overall estimate of 86% sensitivity and 72% specificity
of the CCA POC based on data from 4405 school-age children.
Using microscopy only (KK) as the reference standard, our review,
which incorporated all include study results along with findings of
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additional studies, produced a comparable summary estimate of
89% sensitivity but a lower summary estimate of 55% specificity
at a threshold of trace positive. Differences in specificity could be
explained by the reference standard and indicate that some of the
false-positives identified by CCA POC are indeed likely to be true
infections that are not detected by standard microscopy.
Few studies have fully evaluated the accuracy of the circulating
antigen ELISA tests (CCA and CAA). The serum CAA ELISA
test is currently being converted to a point-of-care format for S.
mansoni (Corstjens 2008) andS. haematobium (van Dam 2013)
with promising results of analytical sensitivity and specificity. In
our review, sensitivity of the included studies evaluating the serum
CAA ELISA test for S. mansoni ranged widely from 47% to 94%,
and specificity ranged widely from 8% to 100%. Sensitivity of
the included studies evaluating the serum CAA ELISA test for S.
haematobium ranged from 55% to 97%, and specificity was low,
ranging from 24% to 57%. However, the studies included in our
review were carried out before the year 2000 with in-house tests.
The tests currently being developed are most likely improved ver-
sions; therefore additional studies analyzing the clinical sensitivity
and specificity of the serum ELISA tests are needed for conclusive
determination of whether they are suitable for the diagnosis of
active schistosomiasis.
Strengths and weaknesses of the review
Strengths
We have evaluated the accuracy of POC tests currently in use
and tests that have recently been transformed into POC tests for
detection of active schistosomiasis in endemic areas. This makes
our review relevant to current practice. To avoid missing studies,
we did not use a search filter, and we did not limit our search by
publication year or language; also to limit bias, data extraction was
performed by two people independently.
Weaknesses
Choice of the reference standard
In light of the absence of a suitable gold standard for active schis-
tosomiasis and the presence of other proposed alternative refer-
ence standards, evaluation of index tests with only microscopy as
the reference standard may be considered a shortcoming of our
review. However because microscopy remains themost commonly
used test and therefore reference test, we wanted our review to be
applicable to current practice. Our review provides better insight
into the proportion of cases detected and the proportion of cases
misclassified by urine reagent strips and CCA POC tests when
microscopy is used as the reference standard. A more reliable way
of evaluating whether an index test can replace microscopy would
be to compare the accuracy of microscopy, urine reagent strips,
and circulating antigen tests against other proposed reference stan-
dards in the same set of participants (direct comparison studies).
A few studies have compared the accuracy of one or more KK
smears and CCA POC against a reference standard comprising six
or more KK smears (Coulibaly 2011; Tchuente 2012; Erko 2013)
or against PCR as the reference test (Lodh 2013) (see comparisons
in Appendix 17). All of these studies have shown the CCA POC
test to be more sensitive but less specific than single or double KK.
More direct comparative studies and reviews are needed to reliably
confirm this finding and to identify sources of variation in results.
Quality of included studies
Poor and inconsistent reporting of participant characteristics such
as clinical status of participants, intensity of infection, adminis-
tration of praziquantel treatment, and conduct of the study lim-
ited our investigations of sources of heterogeneity and risk of bias
assessment.
In our review, the reporting of intensity of infection was unclear
(reported in different ways (arithmetic mean or range of infec-
tion or geometric mean or range of infection or proportions with
light/moderate/heavy infections) or not reported at all) for a large
proportion of the included studies (microhaematuria 44%, pro-
teinuria 42%, and CCA POC 45%). It was therefore difficult to
effectively investigate its influence on the accuracy of the evalu-
ated tests. It was also a challenge to fully investigate the effects
of praziquantel treatment on the accuracy of the evaluated tests
because 82% of the studies did not report the treatment status
of participants before the start of the study. The effects of inten-
sity of infection and the effects of praziquantel treatment on the
accuracy of diagnostic tests for schistosomiasis are currently an
important concern for national control programmes, particularly
as praziquantel treatments progress, with subsequent decreases in
infection intensities. Indeed, in areas where the force of infection
and associated morbidity have been greatly reduced, some pro-
grammes are beginning to focus on elimination. It is therefore of
vital importance that highly sensitive tests are used for monitor-
ing, and that highly sensitive and specific tests are used in efficacy
studies before and after treatment.
Applicability of findings to the review question
Our concern about the applicability of the included studies to our
review question was low, as assessed byQUADAS-2. As all but one
study were carried out in Africa, and all but one study were con-
ducted in field settings, our results are highly applicable for use in
endemic communities for which disease control programmes are
often targeted. However, one area that may limit the applicability
of our findings to the review question is our investigation into
sources of heterogeneity such as effects of praziquantel treatment
and risk of bias assessment on the accuracy estimates of evaluated
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tests. As discussed earlier, poor and inconsistent reporting lim-
ited this investigation. In light of the ongoing disease control pro-
grammes, fully showing any variation in test accuracy associated
with effects of praziquantel treatment would be useful for policy
makers. Knowing the risk of bias of included studies would also
help in objective assessments of the strength of the evidence. Study
authors therefore are encouraged to use the Standards for Report-
ing of Diagnostic Accuracy Studies (STARD) guidelines (Bossuyt
2003) in reporting the design and conduct of their studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Among the tests evaluated for S. haematobium infection, micro-
haematuria has detected the largest proportion of infections and
non-infections identified by microscopy. This test could continue
to serve as a replacement test for microscopy for initial mapping or
estimation of S. haematobium infection, particularly in endemic
areas with moderate to high prevalence of infection.
The CCA POC test for S. mansoni detects a very large proportion
of infections identified by microscopy but misclassifies many mi-
croscopy-negatives as -positives in endemic areas with moderate
to high prevalence of infection. This may occur because the test is
potentially more sensitive than microscopy. Nevertheless, health-
care workers should interpret the results with care when using this
test for initial mapping or estimation of S. mansoni infection, as
some of the positives may still be false-positives, in particular when
trace-positive is used as the threshold.
Besides assessment of the accuracy of a test, the choice of a suitable
diagnostic test should be made in light of cost and logistical con-
siderations. Costs for microscopy (USD per examination, 0.3 for
a single thick KK smear) (Cavalcanti 2013) and for reagent strips
for microhaematuria (USD 0.32) (Legesse 2008) are comparable,
but the strips are easier to use and interpret and therefore are not
logistically challenging in field settings. The CCA POC tests are
more costly (USD 2.6 per examination) (Cavalcanti 2013) but
are rapid and easy to use and interpret, are highly portable, and
require fewer technical personnel than microscopy; they are also
suitable for field screening and diagnosis.
Implications for research
As control programmes progress with expected subsequent de-
creases in prevalence and intensity of infection, we highlight the
importance of additional primary research conducted to identify
a suitable clinical reference standard for active schistosomiasis.
Additional studies comparing the accuracy of microscopy, circu-
lating antigen tests, and urine reagent strips versus other proposed
reference standards are needed if a suitable replacement for mi-
croscopy in practice is to be reliably recommended.
Further studies to identify other sensitive tests to detect active S.
haematobium and S. mansoni infections and further evaluations
of the CAA test as a future POC test for serum or urine are also
needed.
For suitable tests to be reliably recommended for monitoring ef-
fects of praziquantel treatment in disease control programmes, ad-
ditional follow-up studies are required to evaluate the effects of
praziquantel treatment on intensity of infection and accuracy of
urine reagent strips and circulating antigen tests.
Further research on cost-effectiveness of diagnostic tests in areas of
different endemicity is also needed, as cost is a key deciding factor
in resource-limited settings.
Finally, authors of primary test accuracy studies should be encour-
aged to use the STARD guidelines when reporting the design and
conduct of their studies. This will enable systematic reviewers to
better synthesize the data and to draw conclusions on risk of bias
in studies of test accuracy.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abdel-Wahab 1992
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 422
Age range: 12 to 16 years
Participants: school children whose parents gave consent
Setting: field study
Praziquantel status before study: About half of the included children gave a history of receiving
PZQ in past 2 years
Index tests RS-Microhaematuria, RS-Proteinuria, RS-Leukocyturia (Combur-Test, Boehringer, Mannheim,
Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
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Abdel-Wahab 1992 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Leukocyturia
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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Abdel-Wahab 1992 (Continued)
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Abdel-Wahab 2000
Study characteristics
Patient sampling Cross-sectional design; multi-stage stratified random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 5214
Age range: 5 to 25 years
Participants: residents from villages in Fayoum Governorate
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Abdel-Wahab 2000 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Abdel-Wahab 2000 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Adriko 2014˙6KK
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Uganda
Sample size: 469
Age range: 7 to 13 years
Participants: children from 5 schools categorized into 3 settings
Setting: field study
Praziquantel status before study: Annual mass treatment had been administered 5 years before study
began
Index tests CCA POC test
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (6 Kato-Katz smears)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Adriko 2014˙6KK (Continued)
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Adriko 2014˙settingA
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Uganda
Sample size: 100
Age range: 7 to 13 years
Participants: children from 1 school from low endemic setting (setting A)
Setting: field study
Praziquantel status before study: Annual mass treatment had been administered 5 years before study
began
Index tests CCA POC test
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (2 Kato-Katz smears from 1 stool sample)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Adriko 2014˙settingA (Continued)
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Adriko 2014˙settingB
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Uganda
Sample size: 200
Age range: 7 to 13 years
Participants: children from 2 schools from moderate endemic setting (setting B)
Setting: field study
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Adriko 2014˙settingB (Continued)
Praziquantel status before study: Annual mass treatment had been administered 5 years before study
began
Index tests CCA POC test
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (2 Kato-Katz smears from 1 stool sample)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Adriko 2014˙settingB (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Adriko 2014˙settingC
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Uganda
Sample size: 200
Age range: 7 to 13 years
Participants: children from 2 schools from high endemic setting (setting C)
Setting: field study
Praziquantel status before study: Annual mass treatment had been administered 5 years before study
began
Index tests CCA POC test
Target condition and reference
standard(s)
S. mansoni measured by stool microscopy (2 Kato-Katz smears from 1 stool sample)
Flow and timing
Comparative
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Adriko 2014˙settingC (Continued)
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
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Adriko 2014˙settingC (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Alsherbiny 1999
Study characteristics
Patient sampling Cross-sectional design; consecutive enrolment
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 370
Age range: 5 to 75 years
Participants: Occupants > 5 years of age living in Behbeet Village willing to provide a stool, urine,
and blood sample
Setting: field study
Praziquantel status before study: not reported
Index tests CAA ELISA-Serum and Urine; CCA ELISA-Serum and Urine (in-house assays)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Alsherbiny 1999 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
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Alsherbiny 1999 (Continued)
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Anosike 2001
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 1173
Age range: not reported
Participants: all participating households in 7 communities
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Medi-Test Combi-9, Macherey Nagel, Düren, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Anosike 2001 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Anosike 2001 (Continued)
Were all patients included in the
analysis?
Yes
Aryeetey 2000
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 370
Age range: > 5 years
Participants: All participants aged 5 years and above from the 3 study areas
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Hema-Combi-Stix, Bayer Diagnostics, Sudbury, UK)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
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Aryeetey 2000 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Aryeetey 2000 (Continued)
Were all patients included in the
analysis?
Unclear
Ashton 2011
Study characteristics
Patient sampling Nested case-control design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium and S. mansoni
Country: Ivory Coast
Sample size: 370
Age range: 5 to 16 years
Participants: enrolled children within a study, rapid mapping for soil-transmitted helminthiasis
Setting: field study
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. haematobium infectionmeasured by urinemicroscopy (filtrationmethod) and S.mansoni infection
by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
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Ashton 2011 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Ayele 2008
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
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Ayele 2008 (Continued)
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ethiopia
Sample size: 206
Age range: 4 to 21 years
Participants: school children from 1 school, born and grown up in the area, and not moved since
birth
Setting: field
Praziquantel status before study: not reported
Index tests RS-Microhamaturia (Combur 10 test, Roche GmbH, Mannheim, Germany); CCA POC test (Eu-
ropean Veterinary Laboratory (EVL), Woerden, Holland)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Ayele 2008 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
73Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Bassiouny 2014
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Yemen
Sample size: 696
Age range: 10 to 16 years
Participants: primary school children from fifth and sixth grades and first and second grades of
preparatory education
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Urocolor 9, StandardDiagnostics Inc., SuwonCity,Kyonggi Province,Korea)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (sedimentation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Bassiouny 2014 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Birrie 1995˙settingA
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ethiopia
Sample size: 156
Age range: 0 to > 40 years
Participants: all residents invited for checkup (low endemic area)
Setting: field study
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Birrie 1995˙settingA (Continued)
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Multistix Reagent Strips, Ames-Miles, Elkhart, IN, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
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Birrie 1995˙settingA (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Birrie 1995˙settingB
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ethiopia
Sample size: 121
Age range: 0 to > 40 years
Participants: all residents invited for checkup (moderate endemic area)
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Multistix Reagent Strips, Ames-Miles, Elkhart, IN, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
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Birrie 1995˙settingB (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
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Birrie 1995˙settingB (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Birrie 1995˙settingC
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ethiopia
Sample size: 224
Age range: 0 to > 40 years
Participants: all residents invited for checkup (high endemic area)
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Multistix Reagent Strips, Ames-Miles, Elkhart, IN, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Birrie 1995˙settingC (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Bogoch 2012
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 280
Age range: 1 to 77 years
Participants: all willing to participate in voluntary screening and treatment
Setting: field study
Praziquantel status before study: 2 years before study
Index tests RS-Microhaematuria (Combur 10 Test, Roche GmbH, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (centrifugation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Bogoch 2012 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
82Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Bosompem 1996
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 229
Age range: 1 to 86 years
Participants: volunteers
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Ames-Miles, Tokyo, Japan)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (centrifugation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Bosompem 1996 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
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Bosompem 2004
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 141
Age range: not reported
Participants: Urine samples were collected from90 individuals with symptoms and 51 asymptomatic
individuals
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Haemacombrix Strips,Millipore Corp., Billerica,MA,USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Bosompem 2004 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Colley 2013˙Uganda
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Index tests CCA POC cassette test (Rapid Medical Diagnostics; Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni as measured by stool microscopy (1 KK smear)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
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Colley 2013˙Uganda (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Cooppan 1987
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: South Africa
Sample size: 941
Age range: 4 to 20 years
Participants: school children belonging to most infected age group were examined at selected local-
ities
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Labstix, Ames, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
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Cooppan 1987 (Continued)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? No
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? No
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Cooppan 1987 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Coulibaly 2011˙9KK
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Ivory Coast
Sample size: 146
Age range: 8 to 12 years
Participants: children from grades 3 to 5 attending the schools selected for participation in the study
Setting: field study (low endemic area)
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
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Coulibaly 2011˙9KK (Continued)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes In Coulibaly 2011 9KK, the index test was measured against a higher-quality reference standard (9
Kato-Katz smears)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Coulibaly 2011˙9KK (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Coulibaly 2011˙Colley2013
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Ivory Coast
Sample size: 146
Age range: 8 to 12 years
Participants: children from grades 3 to 5 attending the schools selected for participation in the study
Setting: field study (low endemic area)
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
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Coulibaly 2011˙Colley2013 (Continued)
Notes This article describes part of a multi-centre study (Colley 2013). This was similar to Coulibaly
2011 9KK, but this article presented 2-by-2 tables of the CCA POCmeasured against the first daily
stool specimen (triplicate KK smears on 1 stool sample)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
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Coulibaly 2011˙Colley2013 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Coulibaly 2013˙4KK,
Study characteristics
Patient sampling Cohort design; consecutive sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Cote D’ivoire
Sample size: 367
Age range: < 6 years
Participants: all preschool children from 2 villages
Setting: field study
Praziquantel status before study: reported that there had been no treatment in the area
Index tests CCAPOC cassette test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni as measured by stool microscopy (4 Kato-Katz smears)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Coulibaly 2013˙4KK, (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
95Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Coulibaly 2013˙4KK, (Continued)
De Clerq 1995
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Mali
Sample size: 441
Age range: not reported
Participants: Blood and urine samples were collected from 182 and 271 people in the villages of
Kassa and Boro
Setting: field study
Praziquantel status before study: no prior drugs
Index tests CAA ELISA Serum (in-house assay)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CAA ELISA
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De Clerq 1995 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
El-Morshedy 1996
Study characteristics
Patient sampling Cross-sectional design; random sampling
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El-Morshedy 1996 (Continued)
Patient characteristics and set-
ting
Species: S. mansoni
Country: Egypt
Sample size: 257
Age range: 20 to 25 years
Participants: Cohort consisted of 257 men, treated, infected cases in a military camp
Setting: military camp
Praziquantel status before study: no prior drugs
Index tests CAA ELISA Serum (in-house assay)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? No
Low
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El-Morshedy 1996 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
El-Sayed 1995
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 280
Age range: 4 to 36 years
Participants: permanent settlers who agreed to participate in study
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Chemistrip, Boehringer, Indianapolis, IN, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
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El-Sayed 1995 (Continued)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
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El-Sayed 1995 (Continued)
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Were all patients included in the
analysis?
Eltoum 1992
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Sudan
Sample size: 425
Age range: 3 to 39 years
Participants: asymptomatic and symptomatic participants randomly selected from population
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Ames-Miles, Elkhart, IN, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Eltoum 1992 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Eltoum 1992 (Continued)
Were all patients included in the
analysis?
No
Erko 2013˙6KK
Study characteristics
Patient sampling Cross sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Ethiopia
Sample size: 620
Age range: 8 to 12 years
Participants: children from a village in Western Kenya
Setting: field study
Praziquantel status before study: reported that there had been no treatment in the area
Index tests CCA POC cassette test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni as measured by stool microscopy (3 Kato-Katz smears on 3 stool samples (6KK))
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
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Erko 2013˙6KK (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Erko 2013˙Colley 2013
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
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Erko 2013˙Colley 2013 (Continued)
Patient characteristics and set-
ting
Species: S. mansoni
Country: Ethiopia
Sample size: 620
Age range: 8 to 12 years
Participants: children from a village in Western Kenya
Setting: field study
Praziquantel status before study: reported that there had been no treatment in the area
Index tests CCA POC cassette test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni as measured by stool microscopy (3 Kato-Katz smears on 1 stool sample)
Flow and timing
Comparative
Notes This article describes part of a multi-centre study (Colley 2013). This was similar to Erko 2013
6KK, but in this article 2 × 2 tables of the CCA POCmeasured against the first daily stool specimen
(triplicate KK smears on 1 stool sample) were presented
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Erko 2013˙Colley 2013 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Etard 2004
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Mali
Sample size: 2873
Age range: 10 to 22 years
Participants: families from 14 villages
Setting: field study
Praziquantel status before study: Half of the villages had received mass treatment
Index tests RS-Microhaematuria (Ecur test, Boehringer- Mannheim, Germany)
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Etard 2004 (Continued)
Target condition and reference
standard(s)
S. haematobium measured with urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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Etard 2004 (Continued)
of the results of the index tests?
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Fatiregun 2005
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 592
Age range: 11 to 20 years
Participants: all students of junior classes
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Combi-9 Multi-Strip, Macherey Nagel, Düren, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Fatiregun 2005 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Fatiregun 2005 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
French 2007
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 1976
Age range: 6 to 19 years
Participants: school children from 24 sentinel schools
Setting: field study
Praziquantel status before study: Participants were already receiving praziquantel as part of a World
Health Organization (WHO) programme, but no time interval was provided
Index tests RS-Microhaematuria (Haemastix, Bayer, Glasgow, UK)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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French 2007 (Continued)
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Gabr 2000
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 12,134
Age range: 0 to > 55years
Participants: Randomization took place at village and household levels
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Combur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Gabr 2000 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Gigase 1988
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Chad
Sample size: 195
Age range: 7 to 19 years
Participants: children from a village
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Hema-Combi-Stix) (Combur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (centrifugation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Gigase 1988 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Gundersen 1996
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Malawi
Sample size: 260
Age range: 6 to 19 years
Participants: all women of childbearing age (range 15 to 47 years) willing to provide samples,
irrespective of complaints
Setting: outpatient department, hospital
Praziquantel status before study: not reported
115Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Gundersen 1996 (Continued)
Index tests RS-Microhaematuria (Combur Test 9, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Gundersen 1996 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Leukocyturia
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Gundersen 1996 (Continued)
Hall 1999
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 786
Age range: 6 to 16 years
Participants: school-age children from 10 communities
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Hemastix, Bayer, Glasgow, UK)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
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Hall 1999 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
Hammad 1997
Study characteristics
Patient sampling Cross-sectional design; random sampling
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Hammad 1997 (Continued)
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 11,970
Age range: not reported
Participants: participants interviewed and willing to participate in study
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Chemstrip-4 OB, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
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Hammad 1997 (Continued)
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Hammam 2000˙a
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 9555
Age range: 0 > 55 years
Participants: residents from villages and households in Assiut Governorate
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Combur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Hammam 2000˙a (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
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Hammam 2000˙b
Study characteristics
Patient sampling Cross-sectional design; multi-stage stratified cluster sample
Patient characteristics and set-
ting
Species: S. haematobium
Country: Egypt
Sample size: 12,327
Age range: 0 to > 55years
Participants: residents from villages and households in Qena Governorate
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Combur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Hammam 2000˙b (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Houmsou 2011
Study characteristics
Patient sampling Cross-sectional; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 1124
Age range: 3 to 27 years
Participants: those interviewed and willing to participate in study
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Medi-Test Combi 9, Macherey-Nagel, Düren, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Houmsou 2011 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Kassim 1989
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 922
Age range: 5 to 14 years
Participants: school children from Epe and surrounding communities in SW Nigeria
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Labstix, Ames, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (centrifugation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Kassim 1989 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Kiliku 1991
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species:S. haematobium
Country: Kenya
Sample size: 426
Age range: not reported
Participants: sample of all participants in Kwale District
Setting: field study
Praziquantel status before study: no prior drug given
Index tests RS-Microhaematuria, RS-Proteinuria (Uro-Labstix III, Miles-Sanko Co., Ltd., Osaka, Japan)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
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Kiliku 1991 (Continued)
Was quality control done? Yes
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
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King 1988˙a
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Kenya
Sample size: 2628
Age range: 4 to 21 years
Participants: students registered at 5 local primary and secondary schools
Setting: field study
Praziquantel status before study: before and after study; follow-up evaluation 1 year after PZQ and
metrifonate given
Index tests RS-Microhaematuria, RS-Proteinuria (Chemstrip 5 Indicator Dipsticks, Roche Diagnostics, Mon-
treal, Quebec Canada)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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King 1988˙a (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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King 1988˙b
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Kenya
Sample size: 639
Age range: 0 to 60+ years
Participants: residents of a village who submitted urine samples
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Combur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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King 1988˙b (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Kitange 1993
Study characteristics
Patient sampling Cohort design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 253
Age range: not reported
Participants: children in classes 1 to 7 in Melela primary school
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (BM Test 5L, Boehringer, Mannheim, Germany)
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Kitange 1993 (Continued)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (centrifugation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
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Kitange 1993 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Legesse 2007
Study characteristics
Patient sampling Cross sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Ethiopia
Sample size: 251
Age range: 5 to 75 years
Participants: those > 5 years recruited through house-to-house visits
Setting: field study
Praziquantel status before study: not reported
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Legesse 2007 (Continued)
Index tests CCA POC test (Schistosomiasis One Step Test, BV European, Veterinary Laboratory, Woerden,
The Netherlands)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Legesse 2007 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Legesse 2008
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Ethiopia
Sample size: 184
Age range: 5 to 22 years
Participants: primary school children
Setting: field study
Praziquantel status before study: not reported
Index tests CCA POC test (Schistosomiasis One Step Test, BV European, Veterinary Laboratory, Woerden,
The Netherlands)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
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Legesse 2008 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
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Legesse 2008 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Lengeler 1993
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 1208
Age range: 11 to 15 years
Participants: school children who were willing to participate and provided a urine sample
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Combur 9 Multistix, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Lengeler 1993 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Mafe 1997
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 1056
Age range: 5 to > 60 years
Participants: individuals residing in 4 lakeside villages
Setting: field study
Praziquantel status before study: no prior drugs given
Index tests RS-Microhaematuria (Ames Chemical Reagent Strip, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
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Mafe 1997 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Mafe 2000
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 529
Age range: mean 11 years
Participants: school children in Borgo local government area
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Sangur Sticks, Boehringer, Mannheim, Germany)
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Mafe 2000 (Continued)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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Mafe 2000 (Continued)
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Magnussen 2001
Study characteristics
Patient sampling Cohort design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 170
Age range: 11 to 17 years
Participants: All children in class 5 in each school in the district were selected
Setting: field study
Praziquantel status before study: given prior, but time interval not stated
Index tests RS-Microhaematuria (Haemastix, Ames Labs, Ames, IA, USA; Bayer Diagnostics, Sudbury, UK)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Magnussen 2001 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Magnussen 2001 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Midzi 2009
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Zimbabwe
Sample size: 265
Age range: 2 to 19 years
Participants: preschool and primary school children
Setting: field study
Praziquantel status before study: not reported
Index tests CCA POC test (Van Dam version)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Midzi 2009 (Continued)
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Morenikeji 2014
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Uganda
Sample size: 432
Age range: 7 to 13 years
Participants: primary school children
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Medi-Test Combi 10, Standard Diagnostics Inc., Suwon
City, Kyonggi Province, Korea)
Target condition and reference
standard(s)
S. haematobium infection measured bu urine microscopy (centrifugation)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
150Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Morenikeji 2014 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Mott 1985a˙1
Study characteristics
Patient sampling Cohort design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 562
Age range: 5 to 64 years
Participants: those from 5 settlements interviewed and samples collected
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Neostix-3, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
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Mott 1985a˙1 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Mott 1985a˙2
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Zambia
Sample size: 656
Age range: 0 to 64 years
Participants: those in Mutenda
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Neostix-3, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
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Mott 1985a˙2 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Mtasiwa 1996
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 404
Age range: 7 to 15 years
Participants: Urine samples were drawn from 404 pupils, including those with frank haematuria
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Sangur Reagent Sticks, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Mtasiwa 1996 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Murare 1987
Study characteristics
Patient sampling Cohort design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Zimbabwe
Sample size: 232
Age range: 9 to 14 years
Participants: school children from a school chosen on basis of previous studies
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Medi-Test Combi-7, Macherey-Nagel, Düren, Germany)
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Murare 1987 (Continued)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Murare 1987 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Navaratnam 2012
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Uganda
Sample size: 569
Age range: 1 to 5 years
Participants: preschool children living in 4 villages in Buliisa District
Setting: field study
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
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Navaratnam 2012 (Continued)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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Navaratnam 2012 (Continued)
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Ndamukong 2001
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Cameroon
Sample size: 347
Age range: 5 to 16 years
Participants: primary school children attending 6 primary schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Haemastix and Albustix, Bayer, Pittsburgh, PA, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Ndamukong 2001 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
Unclear
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Ndamukong 2001 (Continued)
interpreted without knowledge
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Ndlovu 1996
Study characteristics
Patient sampling Nested case-control design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Zimbabawe
Sample size: 179
Age range: > 5 years
Participants: egg-positives and egg-negatives, resulting in 96 cases and 83 controls from same pop-
ulation
Setting: field study
Praziquantel status before study: not reported
Index tests CAA ELISA Serum (in-house assay)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
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Ndlovu 1996 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Ndlovu 1996 (Continued)
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Nduka 1995
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 1165
Age range: 6 to 21 years
Participants: school children from a rural town
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Medi-Test Combi-9, Macherey Nagel, Düren, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Nduka 1995 (Continued)
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Ndyomugyenyi 2001
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 483
Age range: 5 to 19 years
Participants: children from 3 primary schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Multistix, Ames Labs, Ames, IA, USA; Bayer Diagnostics, Tarrytown, NY,
USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Ndyomugyenyi 2001 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
NGoran 1989
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ivory Coast
Sample size: 1059
Age range: not reported
Participants: inhabitants of village of Nguessan Pokoukro, present on the day of examination
Setting: field study
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NGoran 1989 (Continued)
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Hemastix) (Combur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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NGoran 1989 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
NGoran 1998
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ivory Coast
Sample size: 1336
Age range: 12.2 +/- 1.6 years
Participants: school children from 14 schools in town of Toumoudi
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Sangur-Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
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NGoran 1998 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
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NGoran 1998 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Ngándu 1988
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Zambia
Sample size: 412
Age range: 6 to 19 years
Participants: school children from 9 primary schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Bili-Labstix, Miles, Bridgend, UK)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Ngándu 1988 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
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Ngándu 1988 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Nmorsi 2005
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 300
Age range: 5 to 60 years
Participants: volunteers; excluded were patients with allergy and skin infections
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Haemastix, Ames Laboratories, Ames, IA, USA), RS-Proteinuria (Albustix,
Ames Laboratories)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (centrifugation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Nmorsi 2005 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Unclear
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
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Nmorsi 2005 (Continued)
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Nwaorgu 1992
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 437
Age range: 0 to 35+ years
Participants: permanent settlers who agreed to participate in study
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (L-Combur, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Nwaorgu 1992 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Nwaorgu 1992 (Continued)
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Ofori 1986
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Ghana
Sample size: 118
Age range: not reported
Participants: urine specimens collected from 118 pupils
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (N-Multistix SG, Ames, Glasgow, England)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Ofori 1986 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Ofori 1986 (Continued)
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Okeke 2014˙settingA
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 296
Age range: 5 to 13 years
Participants: primary school children from Niger Lake, a low endemic setting (setting A)
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Medi-Test Combi-9, Macherey-Nagel, Düren, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (sedimentation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Okeke 2014˙settingA (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
Unclear
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Okeke 2014˙settingA (Continued)
interpreted without knowledge
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Okeke 2014˙settingB
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 184
Age range: 5 to 13 years
Participants: primary school children from Nigercem, a moderate endemic setting (setting B)
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Medi-Test Combi-9, Macherey-Nagel, Düren, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (sedimentation method)
Flow and timing
Comparative
Notes
Methodological quality
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Okeke 2014˙settingB (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Okeke 2014˙settingB (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Onayade 1996
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 105
Age range: 8 to 16 years
Participants: all grade 4 to 6 pupils with minimum age of 4
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Proteinuria (N-Multistix, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (sedimentation method)
Flow and timing
Comparative
Notes
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Onayade 1996 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
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Onayade 1996 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Poggensee 2000˙settingA
Study characteristics
Patient sampling Cross-sectional design; non-probability-based sampling procedure
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 175
Age range: 15 to 60 years
Participants: women of childbearing age
Setting: field study (low endemic setting)
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria, RS-Leukocyturia (Nephur-Test + Leuco, Boehringer,
Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
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Poggensee 2000˙settingA (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Leukocyturia
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
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Poggensee 2000˙settingA (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Poggensee 2000˙settingB
Study characteristics
Patient sampling Cross-sectional design; non-probability-based sampling procedure
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 128
Age range: 15 to 60 years
Participants: women of childbearing age
Setting: field study (high endemic setting)
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria, RS-Leukocyturia (Nephur-Test + Leuco, Boehringer,
Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
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Poggensee 2000˙settingB (Continued)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
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Poggensee 2000˙settingB (Continued)
Low
DOMAIN 2: Index Test RS-Leukocyturia
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Polman 1995
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Senegal
Sample size: 422
Age range: 0 to 77 years
Participants: 10% of the households (all members) from an updated census list
Setting: field study
Praziquantel status before study: not reported
Index tests CAA ELISA Serum; CCA ELISA Serum and Urine (in-house)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Polman 1995 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Pugh 1980
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 5367
Age range: 5 to > 36 years
Participants: males 5 to 25 years of age from 3 villages and all participants over 4 years from 2 study
areas
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria; RS-Proteinuria (Labstix, Ames Labs, Berlin, Germany)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Pugh 1980 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Rasendramino 1998
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Madagascar
Sample size: 574
Age range: > 5 years
Participants: all inhabitants of a village > 5 years
Setting: field study
Praziquantel status before study: Study reports that no praziquantel was administered before the
study
Index tests RS-Microhaematuria, RS-Proteinuria, RS-Leukocyturia (Nephur 7 test, Roche Diagnostics, Mon-
treal, Quebec, Canada)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Rasendramino 1998 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Leukocyturia
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
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Rasendramino 1998 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Robinson 2009
Study characteristics
Patient sampling Nested case-control design; quasi-random 2-stage cluster sampling method
Patient characteristics and set-
ting
Species: S. haematobium
Country: Sudan
Sample size: 677
Age range: 5 to 16 years
Participants: In each selected household, children were asked to provide a urine sample
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Hemastix Bayer Diagnostics, Bridgend, UK)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Robinson 2009 (Continued)
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Robinson 2009 (Continued)
Rollinson 2005
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 280
Age range: 10 to 22 years
Participants: children from 2 schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Hemastix, Bayer, Pittsburgh, PA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
199Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Rollinson 2005 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Sarda 1985
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
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Sarda 1985 (Continued)
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 2418
Age range: 7 to 19 years
Participants: children from 12 schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (N-Multistix, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy(filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
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Sarda 1985 (Continued)
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Sarda 1986
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Kenya
Sample size: 1300
Age range: 6 to 19 years
Participants: school children from various schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (N-Multistix Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Sarda 1986 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Savioli 1990
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 879
Age range: 5 to 19 years
Participants: children in a village
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Hemastix, Ames-Miles Laboratories, Elkhart, IN, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Savioli 1990 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Sellin 1982
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Burkina Faso
Sample size: 1162
Age range: not reported
Participants: people from a high endemic village in Upper Volta
Setting: field study
Praziquantel status before study: treatment given after baseline study and follow-up accuracy study
done 1 year later
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Sellin 1982 (Continued)
Index tests RS-Microhaematuria, RS-Proteinuria (Laboratoires Ames, Paris, France)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Sellin 1982 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Shane2011˙Colley2013
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Kenya
Sample size: 1845 (updated from Colley 2013)
Age range: 1 to 15 years
Participants: children from a village in Western Kenya
Setting: field study
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Shane2011˙Colley2013 (Continued)
Praziquantel status before study: reported that there had been no treatment in the area
Index tests CCA POC cassette (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz smears)
Flow and timing
Comparative
Notes This article was part of a multi-centre study (Colley 2013). In this article, 2-by-2 tables of the CCA
POC measured against the first daily stool specimen (duplicate KK smears on 1 stool sample) were
presented
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
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Shane2011˙Colley2013 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Shaw 1998
Study characteristics
Patient sampling Cohort design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Senegal
Sample size: 857
Age range: 4 to > 40
Participants: individuals in households invited to participate
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Ames Labs, Ames, IA, USA; Bayer Diagnostics, Gent, Belgium)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
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Shaw 1998 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
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Shaw 1998 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Standley 2010
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Eastern Lake Victoria (Tanzania and Kenya)
Sample size: 171
Age range: 6 to 17 years
Participants: school children selected in 11 schools by headmaster
Setting: field study
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Standley 2010 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Standley 2010 (Continued)
Stephenson 1984
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Kenya
Sample size: 359
Age range: 6 to 16 years
Participants: Children from 2 primary schools not previously tested were examined
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Ames N-Multistix, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
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Stephenson 1984 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Stephenson 1984 (Continued)
Were all patients included in the
analysis?
Yes
Stothard 2006
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Uganda
Sample size: 270
Age range: 11 years
Participants: children from 9 sentinel schools of matched sexes
Setting: field study
Praziquantel status before study: not reported
Index tests CCA POC test (Schistosomiasis One Step Test, EVL, Woerden, Holland)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
216Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Stothard 2006 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Stothard 2009a
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
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Stothard 2009a (Continued)
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 150
Age range: 8 to 14 years
Participants: children from 5 schools
Setting: field study
Praziquantel status before study: annual MDA 11 months before the study
Index tests CCA POC test (Leiden University Medical Centre, Leiden, The Netherlands)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
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Stothard 2009a (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Stothard 2009b
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 66
Age range: 9 to 15 years
Participants: school children
Setting: field study
Praziquantel status before study: Likely, children enrolled were already part of a ’kick out schistoso-
miasis’ campaign
Index tests RS-Microhaematuria (Hemastix, Bayer, Sudbury, UK)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
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Stothard 2009b (Continued)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
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Stothard 2009b (Continued)
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Tanner 1983˙1
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Liberia
Sample size: 267
Age range: 0 to 15 years
Participants: school children from 3 villages
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Labstix, Ames, Glasgow, England)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Tanner 1983˙1 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Tanner 1983˙1 (Continued)
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Tanner 1983˙2
Study characteristics
Patient sampling Cross-sectional design; random sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 548
Age range: 0 to 15 years
Participants: children from 1 village and river plain
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Blood Sangur Test, Boehringer, Mannheim FRG), RS-Proteinuria (Protein
Albym Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Tanner 1983˙2 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
Unclear
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Tanner 1983˙2 (Continued)
interpreted without knowledge
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Tchuente 2012˙9KK
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Cameroon
Sample size: 138
Age range: 7 to 15 years
Participants: children who provided all 3 samples
Setting: field study (low endemicity)
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Methodological quality
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Tchuente 2012˙9KK (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Tchuente 2012˙9KK (Continued)
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Tchuente 2012˙Colley2013
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Cameroon
Sample size: 138
Age range: 7 to 15 years
Participants: children who provided all 3 samples
Setting: field study (low endemicity)
Praziquantel status before study: not reported
Index tests CCA POC test (Rapid Medical Diagnostics, Pretoria, South Africa)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes This article describes part of a multi-centre study (Colley 2013), which was similar to Tchuente
2012 9KK, but in this article, 2-by-2 tables of the CCA POC measured against the first daily stool
specimen (triplicate KK smears on 1 stool sample) were presented
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Tchuente 2012˙Colley2013 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA POC
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Traore 1998
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Mali
Sample size: 1041
Age range: 2 to 25+ years
Participants: all inhabitants in a village older than 2 years
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Combur-9, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured with urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Traore 1998 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Ugbomoiko 2009a
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 447
Age range: 3 to 17 years
Participants: all school children except girls who hadmenstruated within 5 days of sample collection
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Medi-Test Combi-9, Analyticon Biotechnologies, Rosbach
vor der Höhe, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Ugbomoiko 2009a (Continued)
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Ugbomoiko 2009b˙1
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 566
Age range: > 1 year
Participants: consenting individuals at household level in 5 communities
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (5L test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (sedimentation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Ugbomoiko 2009b˙1 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Ugbomoiko 2009b˙2
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Nigeria
Sample size: 1457
Age range: > 1 year
Participants: consenting participants at central locations in 5 communities
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Combur-9 test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (sedimentation method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Ugbomoiko 2009b˙2 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Van Lieshout 1995
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Surinam
Sample size: 389
Age range: 1 to 85 years
Participants: all inhabitants of a village except those younger than 1 year of age
Setting: field study
Praziquantel status before study: not reported
Index tests CAA and CCA ELISA Serum (in-house assays)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CCA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Van Lieshout 1995 (Continued)
Was quality control done? Unclear
Low
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Van Lieshout 1998˙1
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Zaire
Sample size: 508
Age range: 1 to 66 years
Participants: data set populations living in Maniema-area with intense transmission
Setting: field study
Praziquantel status before study: not reported
Index tests CAA ELISA Serum test
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Van Lieshout 1998˙1 (Continued)
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Van Lieshout 1998˙2
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. mansoni
Country: Senegal
Sample size: 246
Age range: 1 to 77 years
Participants: data set of populations living in Ndombo-area with intense transmission
Setting: field study
Praziquantel status before study: not reported
Index tests CAA ELISA Serum test
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Van Lieshout 1998˙2 (Continued)
Target condition and reference
standard(s)
S. mansoni infection measured by stool microscopy (Kato-Katz)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test CAA ELISA
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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Van Lieshout 1998˙2 (Continued)
of the results of the index tests?
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Verle 1994
Study characteristics
Patient sampling Cross-sectional design; consecutive sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Senegal
Sample size: 352
Age range: 0 to > 50 years
Participants: registered village inhabitants invited to participate
Setting: field study
Praziquantel status before study: not given previously
Index tests RS-Microhaematuria, RS-Proteinuria (Multistix, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium infection measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Verle 1994 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
Unclear
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Verle 1994 (Continued)
interpreted without knowledge
of the results of the index tests?
Was quality control done? Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Warren 1979
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Kenya
Sample size: 390
Age range: 5 to 18 years
Participants: school children from 2 schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria, RS-Proteinuria (Bili-Lab-Stix, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
Methodological quality
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Warren 1979 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Yes
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Warren 1979 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Wilkins 1979
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Gambia
Sample size: 1944
Age range: ≥ 2 years
Participants: study based on specimens collected from earlier study
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Lab-Stix, Ames Labs, Ames, IA, USA)
Target condition and reference
standard(s)
S. haematobium measured by urine microscopy (filtration method)
Flow and timing
Comparative
Notes
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Wilkins 1979 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 2: Index Test RS-Proteinuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
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Wilkins 1979 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Zumstein 1983
Study characteristics
Patient sampling Cross-sectional design; unclear sampling
Patient characteristics and set-
ting
Species: S. haematobium
Country: Tanzania
Sample size: 3478
Age range: 6 to 19 years
Participants: school children form 15 schools
Setting: field study
Praziquantel status before study: not reported
Index tests RS-Microhaematuria (Sangur Test, Boehringer, Mannheim, Germany)
Target condition and reference
standard(s)
S. haematobium measured with urine microscopy (filtration method)
Flow and timing
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Zumstein 1983 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test RS-Microhaematuria
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Was quality control done? Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Was quality control done? Unclear
Low
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Zumstein 1983 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Characteristics of excluded studies [ordered by year of study]
Study Reason for exclusion
Deelder 1981 Not a test accuracy study
Feldmeier 1982 Case-control study with healthy controls
Kassim 1983 Case-control study with healthy controls
Mott 1983 Accuracy study carried out with similar tests and populations as another included paper
Doehring 1985 Not a test accuracy study
Mott 1985 Accuracy study carried out with similar tests and populations as another included paper
Feldmeier 1986 Case series with healthy individuals from “same endemic area”
Madwar 1988 Not a test accuracy study
de Jonge 1988 Case-control study with healthy controls
de Jonge 1989 a Only proven cases included in study
Deelder 1989 Not a test accuracy study
Savioli 1989 Not a test accuracy study
de Jonge 1989 b Only proven cases included in study
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(Continued)
de Jonge 1990 1 Case-control study with controls from non-endemic areas
de Jonge 1990 2 Cannot extract 2-by-2 tables
Taylor 1990 Cannot extract 2-by-2 tables
Lengeler 1991 Cannot extract 2-by-2 tables
Eltoum 1992 b Accuracy study carried out with similar tests and populations as another included paper
van Lieshout 1992 Case-control study with controls from non-endemic areas
Hassan 1992 Ineligible index test
Kaiser 1992 Ineligible reference standard
Gundersen 1992 Case-control study with healthy controls
Krijger 1994 Case-control study with healthy controls
Kremsner 1994 Cannot extract 2-by-2 tables
van Etten 1994 Case-control study with healthy controls
Hassan 1994 Cannot extract 2-by-2 tables
Fillie 1994 Case-control study with healthy controls
Jemaneh 1994 Cannot extract 2-by-2 tables
van Lieshout 1995 Case-control study with controls from non-endemic areas
Hakangard 1996 Case-control study with controls from non-endemic areas
van Etten 1997 Ineligible reference standard
Lwambo 1997 Cannot extract 2-by-2 tables
de Clerq 1997 Cannot extract 2-by-2 tables
Tiemersma 1997 Cannot extract 2-by-2 tables
Disch 1997 Only proven cases included in study
Polman 1998 Not a test accuracy study
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Kahama 1998 Cannot extract 2-by-2 tables
Nibbeling 1998 Ineligible index test
Poggensee 1998 Cannot extract 2-by-2 tables
Pereira 1999 Case-control study with controls from non-endemic areas
Kahama 1999 Not a test accuracy study
Hassan 1999 Only proven cases included in study
Polman 2000 Case-control study with healthy controls
van Dam 2004 Case-control study with controls from non-endemic areas
Brouwer 2004 Cannot extract 2-by-2 tables
Takougang 2004 Cannot extract 2-by-2 tables
Obeng 2008 Case-control study with controls from non-endemic areas
Leutscher 2008 Case-control study with healthy controls
Koukounari 2009 Ineligible reference standard
Stothard 2011 Ineligible reference standard
Verani 2011 Cannot extract 2-by-2 tables
Kosinski 2011 Cannot extract 2-by-2 tables
Coulibaly 2012 Not a test accuracy study
Adesola 2012 Cannot extract 2-by-2 tables
Eyo 2012 Not a test accuracy study
Coulibaly 2013 2 Not a test accuracy study
Lodh 2013 Ineligible reference standard
Grenfell 2013 Not a test accuracy study
Coulibaly 2013 3 Ineligible index test
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(Continued)
Sousa-Figueiredo 2013 Ineligible reference standard
Degarege 2014 Not a test accuracy study
Melchers 2014 Ineligible index test
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 Microhaematuria 74 102447
2 Microhaematuria after treatment 9 7845
3 CCA POC mansoni trace
threshold
15 6091
4 Proteinuria 46 82113
5 Leukocyturia 5 1532
6 CCA POC mansoni +1 threshold 5 1404
7 CCA POC mansoni with good
reference standard
5 2399
8 CCA POC haematobium 4 901
10 CCA POC mixed species 1 373
11 Serum CAA ELISA mansoni 5 1583
12 Serum CAA ELISA
haematobium
3 990
13 Urine CAA ELISA mansoni 1 204
14 Urine CAA ELISA
haematobium
1 370
15 Serum CCA ELISA mansoni 2 569
16 Serum CCA ELISA
haematobium
1 370
17 Urine CCA ELISA mansoni 2 560
19 Urine CCA ELISA
haematobium
1 370
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Test 1. Microhaematuria.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 1 Microhaematuria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abdel-Wahab 1992 80 102 62 178 0.56 [ 0.48, 0.65 ] 0.64 [ 0.58, 0.69 ]
Abdel-Wahab 2000 502 1032 196 3388 0.72 [ 0.68, 0.75 ] 0.77 [ 0.75, 0.78 ]
Anosike 2001 240 106 345 482 0.41 [ 0.37, 0.45 ] 0.82 [ 0.79, 0.85 ]
Aryeetey 2000 1117 335 919 191 0.55 [ 0.53, 0.57 ] 0.36 [ 0.32, 0.41 ]
Ayele 2008 78 11 20 97 0.80 [ 0.70, 0.87 ] 0.90 [ 0.83, 0.95 ]
Bassiouny 2014 78 34 48 536 0.62 [ 0.53, 0.70 ] 0.94 [ 0.92, 0.96 ]
Birrie 1995˙settingA 3 20 2 131 0.60 [ 0.15, 0.95 ] 0.87 [ 0.80, 0.92 ]
Birrie 1995˙settingB 20 17 6 78 0.77 [ 0.56, 0.91 ] 0.82 [ 0.73, 0.89 ]
Birrie 1995˙settingC 54 52 15 103 0.78 [ 0.67, 0.87 ] 0.66 [ 0.58, 0.74 ]
Bogoch 2012 19 18 0 243 1.00 [ 0.82, 1.00 ] 0.93 [ 0.89, 0.96 ]
Bosompem 1996 83 8 26 112 0.76 [ 0.67, 0.84 ] 0.93 [ 0.87, 0.97 ]
Bosompem 2004 33 5 52 51 0.39 [ 0.28, 0.50 ] 0.91 [ 0.80, 0.97 ]
Cooppan 1987 632 21 129 159 0.83 [ 0.80, 0.86 ] 0.88 [ 0.83, 0.93 ]
El-Sayed 1995 9 176 12 440 0.43 [ 0.22, 0.66 ] 0.71 [ 0.68, 0.75 ]
Eltoum 1992 140 123 39 123 0.78 [ 0.71, 0.84 ] 0.50 [ 0.44, 0.56 ]
Etard 2004 596 392 344 1541 0.63 [ 0.60, 0.66 ] 0.80 [ 0.78, 0.81 ]
Fatiregun 2005 49 49 23 471 0.68 [ 0.56, 0.79 ] 0.91 [ 0.88, 0.93 ]
French 2007 219 45 41 1671 0.84 [ 0.79, 0.88 ] 0.97 [ 0.97, 0.98 ]
Gabr 2000 648 1829 426 9007 0.60 [ 0.57, 0.63 ] 0.83 [ 0.82, 0.84 ]
Gigase 1988 101 9 7 78 0.94 [ 0.87, 0.97 ] 0.90 [ 0.81, 0.95 ]
Gundersen 1996 50 158 1 51 0.98 [ 0.90, 1.00 ] 0.24 [ 0.19, 0.31 ]
Hall 1999 5 21 1 759 0.83 [ 0.36, 1.00 ] 0.97 [ 0.96, 0.98 ]
Hammad 1997 712 2408 360 8490 0.66 [ 0.64, 0.69 ] 0.78 [ 0.77, 0.79 ]
Hammam 2000˙a 245 1464 343 7503 0.42 [ 0.38, 0.46 ] 0.84 [ 0.83, 0.84 ]
Hammam 2000˙b 409 2526 257 9134 0.61 [ 0.58, 0.65 ] 0.78 [ 0.78, 0.79 ]
Houmsou 2011 302 68 164 590 0.65 [ 0.60, 0.69 ] 0.90 [ 0.87, 0.92 ]
Kassim 1989 99 11 21 791 0.83 [ 0.75, 0.89 ] 0.99 [ 0.98, 0.99 ]
Kiliku 1991 109 21 64 232 0.63 [ 0.55, 0.70 ] 0.92 [ 0.88, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
(Continued . . . )
255Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
King 1988˙a 1362 47 459 741 0.75 [ 0.73, 0.77 ] 0.94 [ 0.92, 0.96 ]
King 1988˙b 199 38 215 187 0.48 [ 0.43, 0.53 ] 0.83 [ 0.78, 0.88 ]
Kitange 1993 80 17 3 153 0.96 [ 0.90, 0.99 ] 0.90 [ 0.84, 0.94 ]
Lengeler 1993 228 117 66 797 0.78 [ 0.72, 0.82 ] 0.87 [ 0.85, 0.89 ]
Mafe 1997 416 91 190 359 0.69 [ 0.65, 0.72 ] 0.80 [ 0.76, 0.83 ]
Mafe 2000 134 61 38 296 0.78 [ 0.71, 0.84 ] 0.83 [ 0.79, 0.87 ]
Magnussen 2001 107 3 33 27 0.76 [ 0.69, 0.83 ] 0.90 [ 0.73, 0.98 ]
Morenikeji 2014 178 38 65 151 0.73 [ 0.67, 0.79 ] 0.80 [ 0.73, 0.85 ]
Mott 1985a˙1 267 20 121 154 0.69 [ 0.64, 0.73 ] 0.89 [ 0.83, 0.93 ]
Mott 1985a˙2 382 9 74 191 0.84 [ 0.80, 0.87 ] 0.96 [ 0.92, 0.98 ]
Mtasiwa 1996 253 18 20 113 0.93 [ 0.89, 0.95 ] 0.86 [ 0.79, 0.92 ]
Murare 1987 126 12 36 58 0.78 [ 0.71, 0.84 ] 0.83 [ 0.72, 0.91 ]
Ndamukong 2001 169 4 17 157 0.91 [ 0.86, 0.95 ] 0.98 [ 0.94, 0.99 ]
Nduka 1995 38 3 207 917 0.16 [ 0.11, 0.21 ] 1.00 [ 0.99, 1.00 ]
Ndyomugyenyi 2001 194 58 36 195 0.84 [ 0.79, 0.89 ] 0.77 [ 0.71, 0.82 ]
NGoran 1989 160 111 19 256 0.89 [ 0.84, 0.93 ] 0.70 [ 0.65, 0.74 ]
NGoran 1998 102 41 51 1142 0.67 [ 0.59, 0.74 ] 0.97 [ 0.95, 0.98 ]
Ng ndu 1988 130 43 39 200 0.77 [ 0.70, 0.83 ] 0.82 [ 0.77, 0.87 ]
Nmorsi 2005 170 30 43 57 0.80 [ 0.74, 0.85 ] 0.66 [ 0.55, 0.75 ]
Nwaorgu 1992 527 49 53 388 0.91 [ 0.88, 0.93 ] 0.89 [ 0.85, 0.92 ]
Ofori 1986 45 0 19 54 0.70 [ 0.58, 0.81 ] 1.00 [ 0.93, 1.00 ]
Okeke 2014˙settingA 11 8 4 273 0.73 [ 0.45, 0.92 ] 0.97 [ 0.94, 0.99 ]
Okeke 2014˙settingB 21 17 28 118 0.43 [ 0.29, 0.58 ] 0.87 [ 0.81, 0.92 ]
Poggensee 2000˙settingA 4 48 3 120 0.57 [ 0.18, 0.90 ] 0.71 [ 0.64, 0.78 ]
Poggensee 2000˙settingB 44 26 23 35 0.66 [ 0.53, 0.77 ] 0.57 [ 0.44, 0.70 ]
Pugh 1980 415 444 515 3993 0.45 [ 0.41, 0.48 ] 0.90 [ 0.89, 0.91 ]
Rasendramino 1998 352 32 68 95 0.84 [ 0.80, 0.87 ] 0.75 [ 0.66, 0.82 ]
Robinson 2009 135 222 3 317 0.98 [ 0.94, 1.00 ] 0.59 [ 0.55, 0.63 ]
Rollinson 2005 125 16 26 113 0.83 [ 0.76, 0.88 ] 0.88 [ 0.81, 0.93 ]
Sarda 1985 36 32 20 317 0.64 [ 0.50, 0.77 ] 0.91 [ 0.87, 0.94 ]
Sarda 1986 275 54 53 918 0.84 [ 0.79, 0.88 ] 0.94 [ 0.93, 0.96 ]
Savioli 1990 113 38 64 305 0.64 [ 0.56, 0.71 ] 0.89 [ 0.85, 0.92 ]
Sellin 1982 463 356 75 268 0.86 [ 0.83, 0.89 ] 0.43 [ 0.39, 0.47 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Shaw 1998 216 105 121 415 0.64 [ 0.59, 0.69 ] 0.80 [ 0.76, 0.83 ]
Stephenson 1984 151 6 20 182 0.88 [ 0.83, 0.93 ] 0.97 [ 0.93, 0.99 ]
Stothard 2009b 42 9 1 14 0.98 [ 0.88, 1.00 ] 0.61 [ 0.39, 0.80 ]
Tanner 1983˙1 129 10 60 68 0.68 [ 0.61, 0.75 ] 0.87 [ 0.78, 0.94 ]
Tanner 1983˙2 139 42 23 344 0.86 [ 0.79, 0.91 ] 0.89 [ 0.86, 0.92 ]
Traore 1998 420 74 155 392 0.73 [ 0.69, 0.77 ] 0.84 [ 0.80, 0.87 ]
Ugbomoiko 2009a 155 37 72 183 0.68 [ 0.62, 0.74 ] 0.83 [ 0.78, 0.88 ]
Ugbomoiko 2009b˙1 331 25 21 189 0.94 [ 0.91, 0.96 ] 0.88 [ 0.83, 0.92 ]
Ugbomoiko 2009b˙2 595 78 150 630 0.80 [ 0.77, 0.83 ] 0.89 [ 0.86, 0.91 ]
Verle 1994 205 15 101 31 0.67 [ 0.61, 0.72 ] 0.67 [ 0.52, 0.80 ]
Warren 1979 208 3 118 61 0.64 [ 0.58, 0.69 ] 0.95 [ 0.87, 0.99 ]
Wilkins 1979 585 95 493 771 0.54 [ 0.51, 0.57 ] 0.89 [ 0.87, 0.91 ]
Zumstein 1983 134 15 48 199 0.74 [ 0.67, 0.80 ] 0.93 [ 0.89, 0.96 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. Microhaematuria after treatment.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 2 Microhaematuria after treatment
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abdel-Wahab 1992 80 102 62 178 0.56 [ 0.48, 0.65 ] 0.64 [ 0.58, 0.69 ]
Bogoch 2012 19 18 0 243 1.00 [ 0.82, 1.00 ] 0.93 [ 0.89, 0.96 ]
French 2007 368 59 35 2810 0.91 [ 0.88, 0.94 ] 0.98 [ 0.97, 0.98 ]
King 1988˙a 259 65 1178 524 0.18 [ 0.16, 0.20 ] 0.89 [ 0.86, 0.91 ]
Kitange 1993 44 26 0 183 1.00 [ 0.92, 1.00 ] 0.88 [ 0.82, 0.92 ]
Lengeler 1993 8 9 16 187 0.33 [ 0.16, 0.55 ] 0.95 [ 0.91, 0.98 ]
Magnussen 2001 44 10 14 132 0.76 [ 0.63, 0.86 ] 0.93 [ 0.87, 0.97 ]
NGoran 1989 14 6 3 319 0.82 [ 0.57, 0.96 ] 0.98 [ 0.96, 0.99 ]
Shaw 1998 46 84 80 620 0.37 [ 0.28, 0.46 ] 0.88 [ 0.85, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 3. CCA POC mansoni trace threshold.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 3 CCA POC mansoni trace threshold
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Adriko 2014˙settingA 6 42 2 50 0.75 [ 0.35, 0.97 ] 0.54 [ 0.44, 0.65 ]
Adriko 2014˙settingB 40 82 6 72 0.87 [ 0.74, 0.95 ] 0.47 [ 0.39, 0.55 ]
Adriko 2014˙settingC 69 75 3 53 0.96 [ 0.88, 0.99 ] 0.41 [ 0.33, 0.50 ]
Ashton 2011 64 53 8 151 0.89 [ 0.79, 0.95 ] 0.74 [ 0.67, 0.80 ]
Colley 2013˙Uganda 114 199 11 176 0.91 [ 0.85, 0.96 ] 0.47 [ 0.42, 0.52 ]
Coulibaly 2011˙Colley2013 278 42 38 249 0.88 [ 0.84, 0.91 ] 0.86 [ 0.81, 0.89 ]
Coulibaly 2013˙4KK, 52 104 4 82 0.93 [ 0.83, 0.98 ] 0.44 [ 0.37, 0.52 ]
Erko 2013˙Colley 2013 306 103 23 188 0.93 [ 0.90, 0.96 ] 0.65 [ 0.59, 0.70 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Legesse 2007 130 59 21 41 0.86 [ 0.80, 0.91 ] 0.41 [ 0.31, 0.51 ]
Legesse 2008 55 65 12 52 0.82 [ 0.71, 0.90 ] 0.44 [ 0.35, 0.54 ]
Navaratnam 2012 149 181 34 205 0.81 [ 0.75, 0.87 ] 0.53 [ 0.48, 0.58 ]
Shane2011˙Colley2013 231 664 35 833 0.87 [ 0.82, 0.91 ] 0.56 [ 0.53, 0.58 ]
Standley 2010 116 44 1 10 0.99 [ 0.95, 1.00 ] 0.19 [ 0.09, 0.31 ]
Stothard 2006 116 25 24 105 0.83 [ 0.76, 0.89 ] 0.81 [ 0.73, 0.87 ]
Tchuente 2012˙Colley2013 41 31 9 57 0.82 [ 0.69, 0.91 ] 0.65 [ 0.54, 0.75 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 4. Proteinuria.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 4 Proteinuria
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abdel-Wahab 1992 32 31 110 249 0.23 [ 0.16, 0.30 ] 0.89 [ 0.85, 0.92 ]
Abdel-Wahab 2000 97 81 602 4338 0.14 [ 0.11, 0.17 ] 0.98 [ 0.98, 0.99 ]
Aryeetey 2000 610 842 1003 107 0.38 [ 0.35, 0.40 ] 0.11 [ 0.09, 0.13 ]
Bogoch 2012 8 53 11 208 0.42 [ 0.20, 0.67 ] 0.80 [ 0.74, 0.84 ]
Bosompem 1996 44 10 65 110 0.40 [ 0.31, 0.50 ] 0.92 [ 0.85, 0.96 ]
Bosompem 2004 26 17 59 39 0.31 [ 0.21, 0.42 ] 0.70 [ 0.56, 0.81 ]
Cooppan 1987 616 112 145 68 0.81 [ 0.78, 0.84 ] 0.38 [ 0.31, 0.45 ]
Gabr 2000 185 293 889 10540 0.17 [ 0.15, 0.20 ] 0.97 [ 0.97, 0.98 ]
Gundersen 1996 43 163 8 46 0.84 [ 0.71, 0.93 ] 0.22 [ 0.17, 0.28 ]
Hammad 1997 662 3081 410 7817 0.62 [ 0.59, 0.65 ] 0.72 [ 0.71, 0.73 ]
Hammam 2000˙a 155 605 433 8362 0.26 [ 0.23, 0.30 ] 0.93 [ 0.93, 0.94 ]
Hammam 2000˙b 297 1174 369 10487 0.45 [ 0.41, 0.48 ] 0.90 [ 0.89, 0.90 ]
Houmsou 2011 446 216 20 442 0.96 [ 0.93, 0.97 ] 0.67 [ 0.63, 0.71 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kassim 1989 96 98 24 704 0.80 [ 0.72, 0.87 ] 0.88 [ 0.85, 0.90 ]
Kiliku 1991 206 63 58 99 0.78 [ 0.73, 0.83 ] 0.61 [ 0.53, 0.69 ]
King 1988˙a 1343 118 478 670 0.74 [ 0.72, 0.76 ] 0.85 [ 0.82, 0.87 ]
Kitange 1993 27 4 56 166 0.33 [ 0.23, 0.44 ] 0.98 [ 0.94, 0.99 ]
Morenikeji 2014 195 88 48 101 0.80 [ 0.75, 0.85 ] 0.53 [ 0.46, 0.61 ]
Mott 1985a˙1 334 99 38 47 0.90 [ 0.86, 0.93 ] 0.32 [ 0.25, 0.40 ]
Mott 1985a˙2 428 25 75 123 0.85 [ 0.82, 0.88 ] 0.83 [ 0.76, 0.89 ]
Murare 1987 140 25 22 45 0.86 [ 0.80, 0.91 ] 0.64 [ 0.52, 0.75 ]
Ndamukong 2001 155 17 31 144 0.83 [ 0.77, 0.88 ] 0.89 [ 0.84, 0.94 ]
Ng ndu 1988 90 58 79 185 0.53 [ 0.45, 0.61 ] 0.76 [ 0.70, 0.81 ]
Nmorsi 2005 115 25 90 70 0.56 [ 0.49, 0.63 ] 0.74 [ 0.64, 0.82 ]
Nwaorgu 1992 537 85 43 352 0.93 [ 0.90, 0.95 ] 0.81 [ 0.77, 0.84 ]
Ofori 1986 42 13 22 41 0.66 [ 0.53, 0.77 ] 0.76 [ 0.62, 0.87 ]
Okeke 2014˙settingA 8 64 7 217 0.53 [ 0.27, 0.79 ] 0.77 [ 0.72, 0.82 ]
Okeke 2014˙settingB 15 18 34 117 0.31 [ 0.18, 0.45 ] 0.87 [ 0.80, 0.92 ]
Onayade 1996 53 1 41 10 0.56 [ 0.46, 0.67 ] 0.91 [ 0.59, 1.00 ]
Poggensee 2000˙settingA 1 14 6 154 0.14 [ 0.00, 0.58 ] 0.92 [ 0.86, 0.95 ]
Poggensee 2000˙settingB 8 6 59 55 0.12 [ 0.05, 0.22 ] 0.90 [ 0.80, 0.96 ]
Pugh 1980 508 887 422 3550 0.55 [ 0.51, 0.58 ] 0.80 [ 0.79, 0.81 ]
Rasendramino 1998 316 20 104 107 0.75 [ 0.71, 0.79 ] 0.84 [ 0.77, 0.90 ]
Sarda 1985 35 73 21 276 0.63 [ 0.49, 0.75 ] 0.79 [ 0.74, 0.83 ]
Sarda 1986 234 173 94 799 0.71 [ 0.66, 0.76 ] 0.82 [ 0.80, 0.85 ]
Sellin 1982 376 227 162 397 0.70 [ 0.66, 0.74 ] 0.64 [ 0.60, 0.67 ]
Stephenson 1984 113 11 58 177 0.66 [ 0.58, 0.73 ] 0.94 [ 0.90, 0.97 ]
Tanner 1983˙1 108 10 81 68 0.57 [ 0.50, 0.64 ] 0.87 [ 0.78, 0.94 ]
Tanner 1983˙2 136 68 26 318 0.84 [ 0.77, 0.89 ] 0.82 [ 0.78, 0.86 ]
Traore 1998 340 84 235 382 0.59 [ 0.55, 0.63 ] 0.82 [ 0.78, 0.85 ]
Ugbomoiko 2009a 121 45 106 175 0.53 [ 0.47, 0.60 ] 0.80 [ 0.74, 0.85 ]
Ugbomoiko 2009b˙1 206 12 146 202 0.59 [ 0.53, 0.64 ] 0.94 [ 0.90, 0.97 ]
Ugbomoiko 2009b˙2 602 9 147 699 0.80 [ 0.77, 0.83 ] 0.99 [ 0.98, 0.99 ]
Verle 1994 168 21 138 25 0.55 [ 0.49, 0.61 ] 0.54 [ 0.39, 0.69 ]
Warren 1979 123 1 203 63 0.38 [ 0.32, 0.43 ] 0.98 [ 0.92, 1.00 ]
Wilkins 1979 701 251 377 615 0.65 [ 0.62, 0.68 ] 0.71 [ 0.68, 0.74 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
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Test 5. Leukocyturia.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 5 Leukocyturia
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abdel-Wahab 1992 46 20 96 260 0.32 [ 0.25, 0.41 ] 0.93 [ 0.89, 0.96 ]
Gundersen 1996 37 160 14 49 0.73 [ 0.58, 0.84 ] 0.23 [ 0.18, 0.30 ]
Poggensee 2000˙settingA 4 92 3 76 0.57 [ 0.18, 0.90 ] 0.45 [ 0.38, 0.53 ]
Poggensee 2000˙settingB 38 32 29 29 0.57 [ 0.44, 0.69 ] 0.48 [ 0.35, 0.61 ]
Rasendramino 1998 238 30 182 97 0.57 [ 0.52, 0.61 ] 0.76 [ 0.68, 0.83 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 6. CCA POC mansoni +1 threshold.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 6 CCA POC mansoni +1 threshold
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2011 50 9 22 195 0.69 [ 0.57, 0.80 ] 0.96 [ 0.92, 0.98 ]
Coulibaly 2011˙Colley2013 27 6 21 92 0.56 [ 0.41, 0.71 ] 0.94 [ 0.87, 0.98 ]
Coulibaly 2013˙4KK, 43 40 13 146 0.77 [ 0.64, 0.87 ] 0.78 [ 0.72, 0.84 ]
Navaratnam 2012 118 109 65 277 0.64 [ 0.57, 0.71 ] 0.72 [ 0.67, 0.76 ]
Standley 2010 103 17 14 37 0.88 [ 0.81, 0.93 ] 0.69 [ 0.54, 0.80 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 7. CCA POC mansoni with good reference standard.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 7 CCA POC mansoni with good reference standard
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Adriko 2014˙6KK 157 139 21 152 0.88 [ 0.83, 0.93 ] 0.52 [ 0.46, 0.58 ]
Coulibaly 2011˙9KK 213 13 58 159 0.79 [ 0.73, 0.83 ] 0.92 [ 0.87, 0.96 ]
Coulibaly 2013˙4KK, 52 104 4 82 0.93 [ 0.83, 0.98 ] 0.44 [ 0.37, 0.52 ]
Erko 2013˙6KK 306 103 23 188 0.93 [ 0.90, 0.96 ] 0.65 [ 0.59, 0.70 ]
Tchuente 2012˙9KK 322 94 59 150 0.85 [ 0.80, 0.88 ] 0.61 [ 0.55, 0.68 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 8. CCA POC haematobium.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 8 CCA POC haematobium
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2011 29 43 49 159 0.37 [ 0.26, 0.49 ] 0.79 [ 0.72, 0.84 ]
Ayele 2008 51 39 47 69 0.52 [ 0.42, 0.62 ] 0.64 [ 0.54, 0.73 ]
Midzi 2009 84 88 23 70 0.79 [ 0.70, 0.86 ] 0.44 [ 0.36, 0.52 ]
Stothard 2009a 4 2 42 102 0.09 [ 0.02, 0.21 ] 0.98 [ 0.93, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 10. CCA POC mixed species.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 10 CCA POC mixed species
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ashton 2011 111 43 58 161 0.66 [ 0.58, 0.73 ] 0.79 [ 0.73, 0.84 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 11. Serum CAA ELISA mansoni.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 11 Serum CAA ELISAmansoni
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
El-Morshedy 1996 117 0 30 110 0.80 [ 0.72, 0.86 ] 1.00 [ 0.97, 1.00 ]
Polman 1995 325 22 19 2 0.94 [ 0.92, 0.97 ] 0.08 [ 0.01, 0.27 ]
Van Lieshout 1995 27 20 31 126 0.47 [ 0.33, 0.60 ] 0.86 [ 0.80, 0.91 ]
Van Lieshout 1998˙1 449 8 34 17 0.93 [ 0.90, 0.95 ] 0.68 [ 0.46, 0.85 ]
Van Lieshout 1998˙2 222 9 14 1 0.94 [ 0.90, 0.97 ] 0.10 [ 0.00, 0.45 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 12. Serum CAA ELISA haematobium.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 12 Serum CAA ELISA haematobium
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alsherbiny 1999 37 131 30 172 0.55 [ 0.43, 0.67 ] 0.57 [ 0.51, 0.62 ]
De Clerq 1995 199 82 55 105 0.78 [ 0.73, 0.83 ] 0.56 [ 0.49, 0.63 ]
Ndlovu 1996 93 63 3 20 0.97 [ 0.91, 0.99 ] 0.24 [ 0.15, 0.35 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 13. Urine CAA ELISA mansoni.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 13 Urine CAA ELISA mansoni
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Van Lieshout 1995 6 1 52 145 0.10 [ 0.04, 0.21 ] 0.99 [ 0.96, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 14. Urine CAA ELISA haematobium.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 14 Urine CAA ELISA haematobium
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alsherbiny 1999 11 18 56 285 0.16 [ 0.08, 0.27 ] 0.94 [ 0.91, 0.96 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 15. Serum CCA ELISA mansoni.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 15 Serum CCA ELISA mansoni
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Polman 1995 290 12 51 12 0.85 [ 0.81, 0.89 ] 0.50 [ 0.29, 0.71 ]
Van Lieshout 1995 21 10 37 136 0.36 [ 0.24, 0.50 ] 0.93 [ 0.88, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 16. Serum CCA ELISA haematobium.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 16 Serum CCA ELISA haematobium
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alsherbiny 1999 2 29 65 274 0.03 [ 0.00, 0.10 ] 0.90 [ 0.87, 0.93 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 17. Urine CCA ELISA mansoni.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 17 Urine CCA ELISAmansoni
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Polman 1995 316 21 11 8 0.97 [ 0.94, 0.98 ] 0.28 [ 0.13, 0.47 ]
Van Lieshout 1995 36 23 22 123 0.62 [ 0.48, 0.74 ] 0.84 [ 0.77, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 19. Urine CCA ELISA haematobium.
Review: Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
Test: 19 Urine CCA ELISA haematobium
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Alsherbiny 1999 52 90 15 213 0.78 [ 0.66, 0.87 ] 0.70 [ 0.65, 0.75 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. Sources of heterogeneity for urine reagent strip for microhaematuria
Group Co-variate Subgroup n (N = 74) Sensitivity (95% CI) Specificity (95% CI)
Overall 0.75 (0.71-0.79) 0.87 (0.84-0.90)
Subgroup analysis Reference standard Higher quality (> 1
sample)
10 0.71 (0.62-0.80) 0.85 (0.78-0.93)
Lower quality (1
sample)
64 0.76 (0.71-0.80) 0.87 (0.84-0.90)
Threshold ≥ +1 23 0.80 (0.73-0.85) 0.85 (0.78-0.92)
Age Children 34 0.77 (0.71-0.82) 0.91 (0.87-0.93)
Intensity of infec-
tion
Light 28 0.73 (0.66-0.79) 0.88 (0.84-0.92)
Sensitivity analysis Concentration Filtration only 62 0.73 (0.69-0.78) 0.86 (0.82-0.89)
QUADAS Patient
Selection
Low risk of bias 16 0.77 (0.70-0.86) 0.86 (0.79-0.92)
QUADAS
Reference Standard
Low risk of biasa 1 - -
QUADASFlow and
Timing
Low risk of bias 43 0.77 (0.72-0.82) 0.87 (0.83-0.90)
aInsufficient data for synthesis.
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Table 2. Sources of heterogeneity for urine reagent strip for proteinuria
Group Co-variate Subgroup n (N = 46) Sensitivity (95% CI) Specificity (95% CI)
Overall 0.61 (0.53-0.68) 0.82 (0.77-0.88)
Subgroup analysis Reference standard Higher quality (> 1
sample)
9 0.49 (0.28-0.70) 0.83 (0.76-0.90)
Lower quality (1
sample)
37 0.68 (0.60-0.76) 0.78 (0.69-0.87)
Threshold ≥ +1 13 0.69 (0.56-0.81) 0.72 (0.54-0.90)
Age Children 18 0.67 (0.56-0.76) 0.81 (0.74-0.87)
Intensity of infec-
tion
Light 15 0.60 (0.43-0.77) 0.83 (0.73-0.93)
Sensitivity analysis Concentration Filtration only 35 0.62 (0.52-0.71) 0.80 (0.73-0.86)
QUADAS Patient
Selection
Low risk of bias 11 0.64 (0.50-0.79) 0.81 (0.70-0.93)
QUADAS
Reference Standard
Low risk of biasa 1 -
QUADASFlow and
Timing
Low risk of bias 36 0.67 (0.59-0.76) 0.82 (0.73-0.88)
aInsufficient data for synthesis.
Table 3. Sources of heterogeneity for CCA POC test for S. mansoni
Group Co-variate Subgroup n (N = 15) Sensitivity (95% CI) Specificity (95% CI)
Overall 0.89 (0.86-0.92) 0.55 (0.46-0.65)
Subgroup analysis Reference standarda
Higher quality (> 1
sample)
5 0.88 (0.82-0.92) 0.66 (0.46-0.82)
Lower quality (1
sample)
13 0.88 (0.85-0.91) 0.55 (0.45-0.66)
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Table 3. Sources of heterogeneity for CCA POC test for S. mansoni (Continued)
Positivity threshold
b
> +1 5 0.72 (0.60-0.82) 0.85 (0.71-0.93)
Age Children 14 0.90 (0.86-0.92) 0.56 (0.46-0.66)
Intensity of infec-
tion
Lightc 3 - -
Sensitivity analysis QUADAS Patient
Selection
Low risk of biasc 3 - -
QUADAS
Reference Standard
Low risk of biasc 0 - -
QUADASFlow and
Timing
Low risk of bias 11 0.87 (0.84-0.90) 0.57 (0.49-0.65)
aThree studies had data points for evaluations with both a lower- and a higher-quality reference standard.
bFive studies had data points at both thresholds: trace and +1.
cInsufficient data for synthesis.
A P P E N D I C E S
Appendix 1. Geographical distribution, infection, and morbidity of S. haematobium and S. mansoni
Species Geographical
distributiona
Number infected (mil-
lions)
Morbidity (millions)
S. haematobium Africa, Middle East In SSA (112)b Urogenital schistosomiasis
a
Signs and symptoms:
Haema-
turia (blood in urine), pro-
teinuria (proteins in urine)
, leukocyturia (white blood
cells in urine), urinary ob-
struction, hydronephrosis,
chronic renal failure, blad-
der cancer, genital lesions,
In SSAb:
Haematuria (71)
Dysuria (32)
Minor bladder pathology
(76)
Major bladder pathology
(24)
Major hydronephrosis (9.
6)
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(Continued)
vaginal bleeding, pain dur-
ing sexual intercourse,
nodules in the vulva, in-
fertility, pathology in pros-
trate and seminal vesicles
S. mansoni Africa, Middle East, the
Caribbean, South America
In SSA (54)b Intestinal schistosomiasisa
Signs and symptoms:
Abdominal pain, blood in
stool, portal hypertension,
ascites
In SSAb:
Diarrhoea (0.78)
Blood in stool (4.4)
Hepatomegaly (8.5)
Abbreviations: SSA = sub-Saharan Africa.
aWHO 2010.
bvan der Werf 2003.
cWHO/TDR 2006.
Appendix 2. Diagnostic and treatment strategies
Figure 17
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Figure 17. Diagnostic and treatment strategies. Abbreviations: +ve = positive; -ve = negative; CAA =
circulating anodic antigen; CCA = circulating cathodic antigen; M+ = microscopy positive; M- = microscopy
negative; U+ = urine reagent strips positive; U- = urine reagent strips negative; Rx = treatment; No Rx = no
treatment.
Abbreviations: +ve = positive; -ve = negative; CAA = circulating anodic antigen; CCA = circulating cathodic antigen; M+ = microscopy
positive; M- = microscopy negative; U+ = urine reagent strips positive; U- = urine reagent strips negative; Rx = treatment; No Rx = no
treatment.
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Appendix 3. MEDLINE search strategy via Ovid SP platform
Limits: limited to human studies
Line # Term
1 (anodic adj3 antigen*).ti,ab.
2 (cathodic adj3 antigen*).ti,ab.
3 exp Enzyme-Linked Immunosorbent Assay/
4 exp Immunoenzyme Techniques/
5 hematuria/ or exp proteinuria/
6 leukocyturia.ti,ab.
7 leucocyturia.ti,ab.
8 h?ematuria.ti,ab.
9 proteinuria.ti,ab.
10 albuminuria.ti,ab.
11 CCA.ti,ab.
12 CAA.ti,ab.
13 urinalysis.ti,ab.
14 elisa.ti,ab.
15 eia.ti,ab.
16 exp Reagent Strips/ or dipstick.mp.
17 (reagent adj3 strip*).ti,ab.
18 (test adj3 strip*).ti,ab.
19 haemastix.ti,ab.
20 “schistosoma mansoni”.ti,ab. or “schistosoma haematobium”.ti,ab
21 exp Glycoproteins/
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(Continued)
22 exp Antigens, Helminth/
23 exp Helminth Proteins/
24 exp Schistosoma haematobium/
25 exp Antibodies, Monoclonal/
26 exp Schistosoma mansoni/
27 or/1-26
28 schistosomiasis/ or schistosomiasis haematobia/ or schistosomiasis mansoni/
29 schistosomiasis.ti,ab.
30 bilharzia*.ti,ab.
31 or/28-30
32 animals/ not humans/
33 exp Letter/
34 exp Case Reports/
35 or/32-34
36 27 and 31
37 36 not 35
With use of the Ovid platform, this MEDLINE search was translated automatically to suit the EMBASE and BIOSIS databases to
identify additional records. In the search interface, under ’resource selected,’ with the link ’change,’ one can select the desired database.
Appendix 4. QUADAS tool
We used the QUADAS-2 tool. The signalling questions under the four recommended domains are outlined in questions 7 to 10 on
the data extraction form.
The scoring guidance for these questions was as follows.
Flow diagram
For questions 7 and 8, drawing a flow diagram of the study may be helpful (this is not mandatory). Flow charts of patients display how
many patients were eligible for the study, how many were actually recruited, how many received the index test, how many received the
reference standard, etc. In addition, the numbers of true- and false-positives and true- and false-negatives are displayed. If necessary,
please draw a flow diagram for the primary study in the space provided on page 8 of the extraction form.
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7. Patient selection (patient selection domain)
These questions will help assess risks of bias in the study design.
a. Please cite here the selection criteria
Please list in the space provided the selection criteria used to recruit patients into the study. You can also cite the page number in the
article on which the selection criterion was written.
If no criteria were reported, indicate “Not reported/NR” in the space provided. If the criterion was unclear, please indicate “Unclear,”
and explain your answer.
b. Stage of disease
Participants recruited into the study may be without symptoms or with symptoms. Please indicate the disease stage for participants. If
the study clearly reports that both asymptomatic and symptomatic cases were evaluated, please tick the appropriate box provided (both
A and S). If the study does not clearly report the clinical status of the participants, please tick the box ‘Unclear.’ A box N/A has been
provided. If S. m for example was not evaluated in the study, please tick this box. The same applies to S. h. A comment box is provided
for any comments that you may have.
c. What was the study design?
Please indicate the design of the study by ticking one of the choices provided.
We will not include case-control studies that incorporate healthy controls, alternative diagnosis controls, or controls from non-endemic
areas. Research has shown that this type of study overestimates accuracy measures. Healthy controls are those who have been confirmed
as disease-free. Alternative diagnosis controls are controls who have symptoms similar to those of the disease under study.
If the design is not stated or is unclear, please tick the appropriate boxes. If necessary, insert comment into the box provided.
d. Was a consecutive or random sample of patients enrolled?
• Yes: when the authors report random patient sampling or consecutive enrolment.
• No: when patients were selected, for example, based on previous (reference or index) test results.
• Unclear: there seems to be no problem, but the study authors do not explicitly state that patients were enrolled consecutively.
e. Did the study avoid inappropriate exclusions?
• Yes: No patients were excluded after inclusion.
• No: For example, when patients with mild disease were excluded, because they are more difficult to detect.
• Unclear: not reported or insufficient information given to permit a decision.
f. Could the selection of patients have introduced bias?
• High: if one or more of the questions above (7 d-e) was answered with ‘no.’
• Low: if all questions were answered with ‘yes’ (7 d-e), or if at most one question was answered with ‘unclear.’
• Unclear: for any other combination of answers (eg if two or more questions were unclear and the other(s) was/were answered
with ‘yes.’
g. Is there a concern that the included patients do not match the review question?
• High concern: when participants are those who do not reside in endemic areas, such as tourists, healthy controls, or controls
with alternative diagnoses.
• Low concern: when participants in the study are those who reside in schistosomiasis endemic areas. This group will include
those at risk of infection, those who are infected but asymptomatic, or those who are infected with symptoms.
• Unclear: scored when information is insufficient to permit a decision.
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8. Patient flow and timing (Flow and Timing domain)
a. Was there an appropriate interval between index test(s) and reference standard?
• Yes: if urine/stool samples are examined by both the reference standard and the index standard at the same time, or if the time
period is less than one week.
• No: if time period between index and reference standards is longer than one week.
• Unclear: if no or insufficient information on time period is provided.
b. Did all patients receive a reference standard? (focus on those included in 2 × 2 table)
• Yes: scored when the whole sample or a random selection of the sample or a selection of the sample with consecutive series
receive verification using the reference standard.
• No: scored when a part of the sample that is non-randomly or non-consecutively selected receives verification with the reference
standard.
• Unclear: scored when no or insufficient information is provided to ascertain whether the whole sample or a random selection of
the sample received verification with a reference standard.
c. Did patients receive the same reference standard?
• Yes: scored when study participants are tested with the same reference standard, urine/stool microscopy, regardless of index test
result.
• No: scored when microscopy is used with different urine concentration techniques depending on index test results for S.
haematobium.
• Unclear: scored when no or insufficient information is provided on the different reference standards used.
d. Were all patients included in the analysis?
• Yes: scored when the patients who were included in the study were also included in the analysis.
• No: scored when some patients/results are missing.
• Unclear: scored when no or insufficient information is provided to permit a judgement.
e. Could the conduct or interpretation of the flow and timing have introduced bias?
• High: if two or more questions above (8 a-d) were answered with ‘no.’
• Low: if all questions were answered with ‘yes’; or at least three and the other one with unclear.
• Unclear: for any other combination of answers (eg all questions were unclear; three were unclear and the last one was ‘yes’).
Please state the tests under evaluation in the study.
Indicate the tests that have been evaluated for S. mansoni and/or S. haematobium in the study by ticking the appropriate boxes for the
respective species. If a species was not evaluated, please tick the box ‘not applicable.’
9. Index tests (Index test domain)
a. Was quality control done?
To ensure reliability or good quality of results, a sample of slides may be cross-checked by a second person, by an expert, or by a
reference laboratory. Please indicate whether this was done in the study. If information given is unclear, please tick the box ‘unclear.’ If
not reported, tick the box ‘not stated.’ If necessary, provide comment in the box provided.
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b. Were the index test results interpreted without knowledge of the results of the reference standard?
• Yes: when results of the index tests are interpreted without knowledge of reference test results, or when index tests are done
before the reference standard.
• No: when results of the index tests are interpreted with knowledge of reference test results in cases when reference tests were used
before the index tests.
• Unclear: when information on when the index and reference tests were interpreted is insufficient.
• Not stated: when no information was reported on this item.
c. If a threshold was used, was it prespecified?
• Yes: when the study authors report the use of one prespecified cutoff value. A prespecified threshold also includes statements
such as, “the test was scored according to manufacturer’s instructions.”
• No: when multiple cutoff values were tested and the best one chosen afterwards.
• Unclear: when only one cutoff value was used, but this was not explicitly stated in the Methods section.
• Not stated: when no information was reported on this item.
• Could the conduct or interpretation of the index test have introduced bias?
◦ High: if two or more questions above (9 a-c) were answered with ‘no.’
◦ Low: if questions (9 a-c) were answered with ‘yes.’
◦ Unclear: for any other combination of answers (eg both questions were unclear; one was unclear and one was ‘yes’).
10. Reference test (Reference Test domain)
The reference test for S.h that this review will evaluate is urine microscopy.
The following questions (10 A (h-k)) are part of the QUADAS tool and will be used to assess for risk of bias in how the reference
test is carried out.
A. S. haematobium
h. Was quality control done?
To ensure reliability or good quality of results, a sample of slides may be cross-checked by a second person, by an expert, or by a
reference laboratory. Please indicate whether this was done in the study. If information given is unclear, please tick the box ‘unclear.’ If
not reported, tick the box ‘not stated.’ If necessary, insert comment into the box provided.
i. Is the reference standard likely to correctly classify the target condition?
• Yes: if measures to increase sensitivity are used (eg concentration techniques, multiple slides examined, stool sampled over a
number of days. The recommended reference std for microscopy is one carried out on 3 stools or 3 urine samples (grading as follows:
1 sample; poor; 2 samples; moderate; 3 samples; good).
• No: for example, if only ill children are sampled for the reference standard, or if stool samples with blood are thrown away to
avoid contaminating technicians
• Unclear: scored when information on the reference standard used or sample preparation technique used was insufficient.
j. Were the reference standard results interpreted without knowledge of results of the index test?
• Yes: when results of the reference tests are interpreted without knowledge of index test results in cases when reference tests are
used before the index standard.
• No: when results of the reference tests are interpreted with knowledge of the index test results in cases in which index tests are
used before reference tests.
• Unclear: when information on when the index and reference tests were interpreted is insufficient.
• Not stated: when no information on this item was reported.
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k. Could the conduct or interpretation of the reference standard have introduced bias?
• High: if one or both questions above (a-b) were answered with ‘no.’
• Low: if both questions were answered with ‘yes.’
• Unclear: if both questions were unclear; or one was unclear and one was ‘yes.’
B. S. mansoni
Tick the appropriate box for the index tests used to detect S. m in the article.
These questions for S.m should be tackled in a similar fashion to those for S. haematobium.
a. Reference standard
The reference test for S.m that this review will evaluate is microscopy of stool that is prepared by the Kato-Katz method.
b. Was quality control done?
To ensure reliability or good quality of results, a sample of slides may be cross-checked by a second person, by an expert, or by a
reference laboratory. Please indicate whether this was done in the study. If information given is unclear, please tick the box ‘unclear.’ If
not reported, tick the box ‘not stated.’ If necessary, insert comment into the box provided.
The questions 10 B (i-l) are part of the QUADAS tool and will be used to assess for risk of bias in how the reference test is carried out.
Instructions for these questions are similar to those for S. haematobium given above.
Appendix 5. Risk of bias and applicability concerns summary: review authors’ judgements about
each domain for each included study
Figure 18
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Figure 18. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study. The blank cells refer to information that is not applicable to the stated study.
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Appendix 6. Effect of year of study on the accuracy of microhaematuria
Figure 19
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Figure 19. Forest plot showing effect of year of study on sensitivity and specificity of microhaematuria.
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Appendix 7. Effect of test brand on accuracy of microhaematuria
Figure 20
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Figure 20. Summary ROC plot showing effect of test brand on sensitivity and specificity of
microhaematuria.
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Appendix 8. Effect of year of study on the accuracy of proteinuria
Figure 21
Figure 21. Forest plot showing effect of year of study on sensitivity and specificity of proteinuria.
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Appendix 9. Effect of test brand on accuracy of proteinuria
Figure 22
Figure 22. Summary ROC plot showing effect of test brand on sensitivity and specificity of proteinuria.
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Appendix 10. Effect of test brand on accuracy of CCA POC S. mansoni
Figure 23
Figure 23. Summary ROC plot showing effect of test brand on sensitivity and specificity of CCA POC
mansoni.
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Appendix 11. Forest plot of sensitivity and specificity of serum CAA ELISA for S. mansoni
Figure 24
Figure 24. Forest plot of sensitivity and specificity of serum CAA ELISA for S. mansoni.Squares represent
the sensitivity and specificity of one study, the black line its confidence interval.
Squares represent the sensitivity and specificity of one study. The black line shows its confidence interval.
Appendix 12. Summary ROC plot of sensitivity versus specificity of serum CAA ELISA for S.
mansoni
Figure 25
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Figure 25. Summary ROC plot of sensitivity versus specificity of serum CAA ELISA for S. mansoni.The size
of the points is proportional to the study sample size.
The size of the points is proportional to the study sample size.
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Appendix 13. Forest plot of sensitivity and specificity of serum CAA ELISA for S. haematobium
Figure 26
Figure 26. Forest plot of sensitivity and specificity of serum CAA ELISA for S. haematobium.Squares
represent the sensitivity and specificity of one study, the black line its confidence interval.
Squares represent sensitivity and specificity of one study. The black line shows its confidence interval.
Appendix 14. Summary ROC plot of sensitivity versus specificity of serum CAA ELISA for S.
haematobium
Figure 27
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Figure 27. Summary ROC plot of sensitivity versus specificity of serum CAA ELISA for S.
haematobium.The size of the points is proportional to the study sample size
The size of the points is proportional to the study sample size.
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Appendix 15. Forest plot of sensitivity and specificity of serum CCA ELISA for S. mansoni
Figure 28
Figure 28. Forest plot of sensitivity and specificity of serum CCA ELISA for S. mansoni.Squares represent
the sensitivity and specificity of one study, the black line its confidence interval.
Squares represent sensitivity and specificity of one study. The black line shows its confidence interval.
Appendix 16. Forest plot of sensitivity and specificity of urine CCA ELISA for S. mansoni
Figure 29
Figure 29. Forest plot of sensitivity and specificity of urine CCA ELISA for S. mansoni.Squares represent
the sensitivity and specificity of one study, the black line its confidence interval.
Squares represent sensitivity and specificity of one study. The black line shows its confidence interval.
Appendix 17. Comparison of KK smears and CCA POC against other reference standards (as
reported by study authors)
Study Ref std Index test
KK 1 CCA
Sensitivity Specificity Sensitivity Specificity
Coulibaly 2011
Setting C
9KK 1 KK 83 (76-88) 100 (77-100) 90 (83-94) 85 (55-99)
2 KK 86 (80-91) 100 (77-100)
3 KK 94 (89-97) 100 (77-100)
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(Continued)
Tchuente 2012 9KK 1 KK 54 (49-59) 100 84 (81-88) 61 (55-68)
3 KK 68 (64-74) 100
Erko 2013 6KK 1 KK 70 (65-75) 100 93 (90-96) 65 (59-70)
2 KK 81 (77-85) 100
Lodh 2013 PCR 1 KK 57 (47-68) 100 (69-100) 67 (56-77) 60 (26-88)
F E E D B A C K
Feedback from Dr Charles King, 17 March 2015
Summary
Point 1:
I feel that the current review’s results and conclusions are misleading. The inappropriate analysis used in the HSROC estimation results
in incorrect conclusions about the diagnostic performance of both antigen tests and dipsticks. The main objection I have is to the use
of microscopic detection of eggs as the reference standard for the diagnosis of Schistosoma infection. Microscopy to detect S. mansoni
or S. japonicum eggs in stool or S. haematobium eggs in filtered urine has long been known to be poorly sensitive for moderate and low
intensity infections. When subjects are repeatedly tested for 7-15 days in a row, single day egg visualization has a sensitivity of 40-60%.
The poor performance of microscopy for S. mansoni has been well documented by de Vlas and colleagues [1, 2] for S. japonicum by
Carabin, et al.[3] and Hubbard, et al. [4] and for S. haematobium by Savioli et al.[5] and Warren, et al [6], among others.
Point 2:
Given the lack of a true ‘gold standard’ and a sensitivity by microscopy of ~50%, a more appropriate approach for the review would
have been Latent Class Analysis (LCA), in which results from two or more imperfect tests are used together to estimate an unmeasured
‘true’ infection status. In stating that the antigen test ’misclassify’ (i.e., have poor specificity), the review claims that a person with a
positive POC CCA and negative stool examination is not infected. In fact, several lines of evidence appear to indicate that many if not
most of those who have negative stool examinations but positive POC CCA results are, in fact, infected. [7, 8, 9, 10, 11]
Point 3:
I would also encourage the authors to include results from populations or areas without significant Schistosoma risk. Measuring results
among persons with very low pre-test probability of infection can contribute greatly to assessing the specificity of new tests.
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Point 4:
Could the authors revisit the data using the LCA approach of Dendukuri, et al., 2012 [12] for situations in which there is no gold
standard? Their SAS code is available online, and the reanalysis could be done in a matter of a day. A revised review, reflecting the LCA
approach, would do much to remove the confusion about these tests in policy circles.
I agree with the conflict of interest statement below:
I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of
my feedback.
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Reply
Point 1:
We would like to thank Professor King for his comment, although we do believe that the analysis used was appropriate. The limitations
of microscopy as a reference standard have been acknowledged several times in our review. In the main text, we interpret the sensitivity
of all tests as percentage of microscopy positives retrieved by the index test; and the specificity as microscopy negatives found negative
by the index test. We therefore believe that our review gives better insight in the proportion of cases detected and missed by microscopy,
which is still a commonly used tool in practice. Our discussion and conclusion within the main text and abstract reflect this. However
we agree that the final line of the Plain Language Summary may be misleading, and we have therefore corrected this, incorporating the
likely low sensitivity of egg counts (see below).
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Moreover, attempts have been made by researchers to improve the quality of the microscopy (by increasing the number of samples
or slides used) as the reference standard. A higher quality reference standard may be expected to detect more of the lower intensity
infections. We showed how this affects the index test’s estimates. For S. mansoni, in studies with a higher quality reference standard the
specificity of the POC-CCA increased. This strongly supports our, and your, conclusion that the apparent low specificity of POC-CCA
is due to low sensitivity of the microscopy reference standard. POC-CCA may be more sensitive than Kato-Katz, particularly in low
endemicity areas. Conversely, for S.haematobium the sensitivity of microhaematuria was lower in studies using a higher quality reference
standard. The extra infections found by the higher quality reference standard were not picked up by microhaematuria dipsticks.
Point 2:
The proposed latent class analysis (LCA) approach for meta-analysis of diagnostic accuracy data takes into account the imperfect nature
of the reference standard to come to a ‘true’ sensitivity and specificity. However, in latent class models, the target condition is a statistical
entity and is not defined in a clinical way. The interpretation and use of accuracy results based on latent class models may therefore
be challenging in practice, as clinicians are unclear about the target condition or what the results stand for. This target condition may
reflect infection status, but there may also be another, unknown underlying latent patient status that does not necessarily correlate with
infection. At least in our meta-analyses, we know what the limitations are and we know how to interpret the results.
We agree that ‘misclassify’ may not be the appropriate term and we will replace it in the abstract of the review with the first update.
We have corrected the Plain Language Summary, incorporating the likely low sensitivity of egg counts. The end of the plain language
summary now states
“For intestinal schistosomiasis, the parasite antigen urine test classifies many microscopy negative people as being infected. This finding
may be explained by the low sensitivity of microscopy.”
Point 3:
We understand the value of assessing the accuracy of these tests in non-endemic areas. However, we wanted to focus our review to
endemic populations where disease control programs are mostly based and where diagnostic methods and control interventions are
mostly applied. Yet, in the discussion we have included comments on the high specificity of POC-CCA tests in non-endemic areas.
This was to strengthen our argument that the low specificity calculated from our meta analyses is likely due to low sensitivity of the
commonly used reference standard (i.e. microscopy).
Point 4:
As explained above, the interpretation of LCA results may not be as straightforward as indicated. Moreover, the validity of results
produced by LCA models depends on the specifications of the statistical model and the assumptions made when modelling the data.
Especially determining the appropriate levels of dependence between tests complicates interpretation and the actual conduct of the
models.
In summary, we whole heartedly agree on the potential benefits of LCA, but would like to see more research done on the validity,
variability and interpretation of the models before using it at a regular basis and accepting it as the true gold standard approach for
these meta-analyses in infectious diseases.
Contributors
All authors contributed to drafting this response.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Title of the review: To make the title of the review more specific to the tests that we evaluated, we have changed the title from “Rapid
diagnostic tests for human schistosomiasis in endemic areas” to “Circulating antigen tests and urine reagent strips for diagnosis of active
schistosomiasis in endemic areas.”
We used QUADAS-2 to assess the methodological quality of studies included in the review. In the protocol, we stated that we would
use the original QUADAS tool to assess quality and planned to perform a sensitivity analysis of the individual quality (QUADAS)
items 4, 7, 8, 10, and 11, to explore whether the results that we found are robust for methodological challenges. Items 10 and 11 are
not included in QUADAS-2. We instead assessed whether reference tests could classify the target condition as a co-variate.
In the protocol, we stated that we would analyze the intensity of infection as numerical co-variates. Because of poor reporting, we
converted the data into categorical co-variates, including intensity of infection (light, moderate, heavy, unclear).
In the protocol, we also stated that we would estimate the sensitivity of urine reagent strips and urine CCA POC at positivity thresholds
of +1 and ≥ +1. Instead we estimated the accuracy at thresholds > trace and > +1, as these data were most commonly provided.
As part of the post hoc analyses, we noted that three evaluations had substantial heterogeneity for the tests microhaematuria (Aryeetey
2000; sensitivity 55%, specificity 36%), proteinuria (Aryeetey 2000; sensitivity 38%, specificity 11%), and CCA POC for S. mansoni
(Standley 2010; sensitivity 99%, specificity 19%). We excluded these evaluations in sensitivity analyses for the respective tests, as shown
in the Results section.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Reagent Strips; ∗Schistosoma haematobium [immunology]; ∗Schistosoma mansoni [immunology]; Antigens, Helminth [blood];
Cross-Sectional Studies; Hematuria [diagnosis]; Microscopy; Prevalence; Proteinuria [diagnosis]; Reference Standards; Schistosomiasis
haematobia [blood; ∗diagnosis; immunology; urine]; Schistosomiasis mansoni [blood; ∗diagnosis; immunology; urine]; Sensitivity and
Specificity
MeSH check words
Adult; Animals; Child; Female; Humans; Male
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